Document:

EX-4.4

 Exhibit 4.4 

AEGLEA BIOTHERAPEUTICS, INC. 

And 

                    , as Trustee 

INDENTURE 
 Dated as of
                    , 

 TABLE OF CONTENTS 

 

					
	 ARTICLE 1 – DEFINITIONS AND INCORPORATION BY REFERENCE
	  	 	1	 
	 1.1 DEFINITIONS
	  	 	1	 
	 1.2. OTHER DEFINITIONS
	  	 	4	 
	 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT
	  	 	4	 
	 1.4. RULES OF CONSTRUCTION
	  	 	4	 
	 ARTICLE 2 – THE SECURITIES
	  	 	5	 
	 2.1. ISSUABLE IN SERIES
	  	 	5	 
	 2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES
	  	 	5	 
	 2.3. EXECUTION AND AUTHENTICATION
	  	 	6	 
	 2.4. REGISTRAR AND PAYING AGENT
	  	 	7	 
	 2.5. PAYING AGENT TO HOLD ASSETS IN TRUST
	  	 	7	 
	 2.6. SECURITYHOLDER LISTS
	  	 	8	 
	 2.7. TRANSFER AND EXCHANGE
	  	 	8	 
	 2.8. REPLACEMENT SECURITIES
	  	 	8	 
	 2.9. OUTSTANDING SECURITIES
	  	 	8	 
	 2.10. WHEN TREASURY SECURITIES DISREGARDED; DETERMINATION OF HOLDERS’ ACTION
	  	 	9	 
	 2.11. TEMPORARY SECURITIES
	  	 	9	 
	 2.12. CANCELLATION
	  	 	9	 
	 2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST
	  	 	9	 
	 2.14. CUSIP NUMBER
	  	 	10	 
	 2.15. PROVISIONS FOR GLOBAL SECURITIES
	  	 	10	 
	 2.16. PERSONS DEEMED OWNERS
	  	 	11	 
	 ARTICLE 3 – REDEMPTION
	  	 	11	 
	 3.1. NOTICES TO TRUSTEE
	  	 	11	 
	 3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED
	  	 	11	 
	 3.3. NOTICE OF REDEMPTION
	  	 	11	 
	 3.4. EFFECT OF NOTICE OF REDEMPTION
	  	 	12	 
	 3.5. DEPOSIT OF REDEMPTION PRICE
	  	 	12	 
	 3.6. SECURITIES REDEEMED IN PART
	  	 	12	 
	 ARTICLE 4 – COVENANTS
	  	 	12	 
	 4.1. PAYMENT OF SECURITIES
	  	 	12	 
	 4.2. SEC REPORTS
	  	 	13	 
	 4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS
	  	 	13	 
	 4.4. COMPLIANCE CERTIFICATE
	  	 	13	 
	 4.5. CORPORATE EXISTENCE
	  	 	13	 
	 ARTICLE 5 – SUCCESSOR CORPORATION
	  	 	13	 
	 5.1. LIMITATION ON CONSOLIDATION, MERGER AND SALE OF ASSETS
	  	 	13	 
	 5.2. SUCCESSOR PERSON SUBSTITUTED
	  	 	14	 
	 ARTICLE 6 – DEFAULTS AND REMEDIES
	  	 	14	 
	 6.1. EVENTS OF DEFAULT
	  	 	14	 
	 6.2. ACCELERATION
	  	 	15	 
	 6.3. REMEDIES
	  	 	15	 
	 6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT
	  	 	15	 
	 6.5. CONTROL BY MAJORITY
	  	 	15	 
	 6.6. LIMITATION ON SUITS
	  	 	16	 
	 6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT
	  	 	16	 
	 6.8. COLLECTION SUIT BY TRUSTEE
	  	 	16	 
	 6.9. TRUSTEE MAY FILE PROOFS OF CLAIM
	  	 	16	 
	 6.10. PRIORITIES
	  	 	17	 
	 6.11. UNDERTAKING FOR COSTS
	  	 	17	 
	 ARTICLE 7 – TRUSTEE
	  	 	17	 
	 7.1. DUTIES OF TRUSTEE
	  	 	17	 
	 7.2. RIGHTS OF TRUSTEE
	  	 	18	 
	 7.3. INDIVIDUAL RIGHTS OF TRUSTEE
	  	 	18	 
	 7.4. TRUSTEE’S DISCLAIMER
	  	 	18	 
	 7.5. NOTICE OF DEFAULT
	  	 	19	 

  
 i 

					
	 7.6. REPORTS BY TRUSTEE TO HOLDERS
	  	 	19	 
	 7.7. COMPENSATION AND INDEMNITY
	  	 	19	 
	 7.8. REPLACEMENT OF TRUSTEE
	  	 	19	 
	 7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION
	  	 	20	 
	 7.10. ELIGIBILITY; DISQUALIFICATION
	  	 	20	 
	 7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY
	  	 	20	 
	 7.12. PAYING AGENTS
	  	 	20	 
	 ARTICLE 8 – AMENDMENTS, SUPPLEMENTS AND WAIVERS
	  	 	21	 
	 8.1. WITHOUT CONSENT OF HOLDERS
	  	 	21	 
	 8.2. WITH CONSENT OF HOLDERS
	  	 	21	 
	 8.3. COMPLIANCE WITH TRUST INDENTURE ACT
	  	 	22	 
	 8.4. REVOCATION AND EFFECT OF CONSENTS
	  	 	22	 
	 8.5. NOTATION ON OR EXCHANGE OF SECURITIES
	  	 	22	 
	 8.6. TRUSTEE TO SIGN AMENDMENTS, ETC.
	  	 	22	 
	 ARTICLE 9 – DISCHARGE OF INDENTURE; DEFEASANCE
	  	 	22	 
	 9.1. DISCHARGE OF INDENTURE
	  	 	22	 
	 9.2. LEGAL DEFEASANCE
	  	 	23	 
	 9.3. COVENANT DEFEASANCE
	  	 	23	 
	 9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE
	  	 	23	 
	 9.5. DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER
MISCELLANEOUS PROVISIONS
	  	 	24	 
	 9.6. REINSTATEMENT
	  	 	24	 
	 9.7. MONEYS HELD BY PAYING AGENT
	  	 	25	 
	 9.8. MONEYS HELD BY TRUSTEE
	  	 	25	 
	 ARTICLE 10 – MISCELLANEOUS
	  	 	25	 
	 10.1. TRUST INDENTURE ACT CONTROLS
	  	 	25	 
	 10.2. NOTICES
	  	 	25	 
	 10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS
	  	 	26	 
	 10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT
	  	 	26	 
	 10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION
	  	 	26	 
	 10.6. RULES BY TRUSTEE AND AGENTS
	  	 	26	 
	 10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT
	  	 	27	 
	 10.8. GOVERNING LAW
	  	 	27	 
	 10.9. NO ADVERSE INTERPRETATION OF OTHER AGREEMENTS
	  	 	27	 
	 10.10. NO RECOURSE AGAINST OTHERS
	  	 	27	 
	 10.11. SUCCESSORS
	  	 	27	 
	 10.12. MULTIPLE COUNTERPARTS
	  	 	27	 
	 10.13. TABLE OF CONTENTS, HEADINGS, ETC.
	  	 	27	 
	 10.14. SEVERABILITY
	  	 	27	 
	 10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS
	  	 	28	 
	 10.16. JUDGMENT CURRENCY
	  	 	28	 

  
 ii 

 INDENTURE, dated as of
                ,                 , by and between Aeglea BioTherapeutics, Inc., a
Delaware corporation, as Issuer (the “Company”) and                 , a
                 organized under the laws of                 , as Trustee (the
“Trustee”). 
 RECITALS OF THE COMPANY 

The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debentures,
notes or other evidences of indebtedness to be issued in one or more series (the “Securities”), as herein provided, up to such principal amount as may from time to time be authorized in or pursuant to one or more resolutions of the Board
of Directors or by supplemental indenture. 
 All things necessary to make this Indenture a valid agreement of the Company in accordance
with its terms have been done, and the execution and delivery thereof have been in all respects duly authorized by the parties hereto. 

NOW, THEREFORE, THIS INDENTURE WITNESSETH: 

For and in consideration of the premises and the purchase of the Securities by the Holders thereof, it is mutually agreed, for the equal and
proportionate benefit of all Holders of the Securities of a Series thereof, as follows: 
 ARTICLE 1 – 

DEFINITIONS AND INCORPORATION BY REFERENCE 

1.1 DEFINITIONS. 

“Affiliate” of any specified Person means any other Person which, directly or indirectly through one or more intermediaries,
controls, or is controlled by or is under common control with, such specified Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and
“under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of
voting securities, by agreement or otherwise. 
 “Agent” means any Registrar, Paying Agent,
co-registrar or agent for service of notices and demands. 
 “Board of Directors” means
the Board of Directors of the Company or any committee duly authorized to act therefor. 
 “Board Resolution” means a copy of a
resolution certified pursuant to an Officers’ Certificate to have been duly adopted by the Board of Directors of the Company and to be in full force and effect on the date of such certification which has been delivered to the Trustee. 

“Capital Stock” means, with respect to any Person, any and all shares or other equivalents (however designated) of capital stock,
partnership interests or any other participation, right or other interest in the nature of an equity interest in such Person or any option, warrant or other security convertible into any of the foregoing. 

“Company” means the party named as such in the first paragraph of this Indenture until a successor replaces such party pursuant to
Article 5 of this Indenture, and thereafter means the successor and any other primary obligor on the Securities. 
 “Company
Order” means a written order signed in the name of the Company by two Officers, one of whom must be its Chief Executive Officer or its Chief Financial Officer. 

“Company Request” means any written request signed in the name of the Company by its Chief Executive Officer, its President, any
Vice President, its Chief Financial Officer or its Treasurer and attested to by its Secretary or any Assistant Secretary. 
 “Corporate
Trust Office” means the office of the Trustee at which at any particular time its corporate trust business shall be principally administered. 

“Default” means any event that is, or that with the passing of time or giving of notice or both would be, an Event of Default. 

“Depository” means, with respect to the Securities of any Series issuable or issued in whole or in part in the form of one or
more Global Securities, the Person designated as Depository for such Series by the Company, which Depository shall be a clearing agency 

  
 1 

 
registered under the Exchange Act, until a successor Depository shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Depository” shall mean
each Person who is then a Depository hereunder, and if at any time there is more than one such Person, such Persons. 
 “Dollars”
means the currency of the United States of America. 
 “Euro” means the single currency of participating member states of the
economic and monetary union as contemplated in the Treaty on European Union. 
 “Exchange Act” means the Securities Exchange Act
of 1934, as amended. 
 “Foreign Currency” means any currency or currency unit issued by a government other than the government of
the United States of America. 
 “Foreign Government Obligations” means, with respect to Securities that are denominated in a
Foreign Currency, (i) direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised
by, or acting as an agency or instrumentality of, such government, the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i) and (ii), are not
callable or redeemable at the option of the issuer thereof. 
 “GAAP” means generally accepted accounting principles consistently
applied as in effect in the United States of America from time to time. 
 “Global Security” or “Global Securities”
means a Security or Securities, as the case may be, in the form established pursuant to Section 2.2, evidencing all or part of a Series of Securities issued to the Depository for such Series or its nominee, and registered in the name
of such Depository or nominee, and bearing the legend set forth in Section 2.15(c) (or such other legend(s) as may be applied to such Securities in accordance with Section 2.2(24)). 

“Holder” or “Securityholder” means the Person in whose name a Security is registered on the Registrar’s books. 

“Indebtedness” means (without duplication), with respect to any Person, any indebtedness at any time outstanding, secured or
unsecured, contingent or otherwise, which is for borrowed money (whether or not the recourse of the lender is to the whole of the assets of such Person or only to a portion thereof), or evidenced by bonds, notes, debentures or similar instruments,
or representing the balance, deferred and unpaid, of the purchase price of any property (excluding any balances that constitute accounts payable or trade payables, and other accrued liabilities arising in the ordinary course of business), if and to
the extent any of the foregoing indebtedness would appear as a liability upon a balance sheet of such Person prepared in accordance with GAAP. 

“Indenture” means this Indenture as amended, restated or supplemented from time to time. 

“Interest Payment Date,” when used with respect to any Security, means the Stated Maturity of an installment of interest on such
Security. 
 “Lien” means, with respect to any property or assets of any Person, any mortgage or deed of trust, pledge,
hypothecation, assignment, deposit arrangement, security interest, lien, charge, easement, encumbrance, preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever on or with respect to such property
or assets (including, without limitation, any capitalized lease obligation, conditional sales or other title retention agreement having substantially the same economic effect as any of the foregoing). 

“Maturity,” when used with respect to any Security, means the date on which the principal of such Security, or an installment of
principal, becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption, notice of option to elect payment or otherwise. 

“Officer” means the Chief Executive Officer, the President, any Vice President, the Chief Financial Officer, the Treasurer or the
Secretary of the Company, or any other officer designated by the Board of Directors, as the case may be. 
 “Officers’
Certificate” means, with respect to any Person, a certificate signed by the Chairman, Chief Executive Officer, President, any Vice President or Secretary and the Chief Financial Officer or any Treasurer of such Person, that shall comply with
applicable provisions of this Indenture. 

  
 2 

 “Opinion of Counsel” means a written opinion from legal counsel, which counsel is
reasonably acceptable to the Trustee. The counsel may be an employee of or outside counsel to the Company. 
 “Person” means any
individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, unincorporated organization or government (including any agency or political subdivision thereof). 

“Redemption Date,” when used with respect to any Security to be redeemed, means the date fixed for such redemption pursuant to this
Indenture. 
 “Responsible Officer,” when used with respect to the Trustee, means any officer within the corporate trust
department or division of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers, and also means, with respect to a
particular corporate trust matter, any other officer to whom such matter is referred because of his knowledge of and familiarity with the particular subject. 

“SEC” means the United States Securities and Exchange Commission as constituted from time to time, or any successor performing
substantially the same functions. 
 “Securities” means the securities that are issued under this Indenture, as amended, restated
or supplemented from time to time pursuant to this Indenture. 
 “Securities Act” means the Securities Act of 1933, as amended.

 “Series” or “Series of Securities” means each series of debentures, notes or other debt instruments of the
Company created pursuant to Sections 2.1 and 2.2. 
 “Significant Subsidiary” means (i) any direct or indirect
Subsidiary of the Company that would be a “significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to
the Securities Act, as such regulation is in effect on the date hereof, or (ii) any group of direct or indirect Subsidiaries of the Company that, taken together as a group, would be a “significant subsidiary” as defined in
Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the date hereof. 

“Stated Maturity,” when used with respect to any Security or any installment of principal thereof or interest thereon, means the
date specified in such Security as the fixed date on which the principal of such Security and the interest thereon, or such installment of principal or interest, is due and payable, and when used with respect to any other Indebtedness, means the
date specified in the instrument governing such Indebtedness as the fixed date on which the principal of such Indebtedness, or any installment of interest thereon, is due and payable. 

“Subsidiary” of any specified Person means any corporation, limited liability company, partnership, joint venture, association or
other business entity, whether now existing or hereafter organized or acquired, (i) in the case of a corporation, of which more than 50% of the total voting power of the Capital Stock entitled (without regard to the occurrence of any
contingency) to vote in the election of directors thereof is held, directly or indirectly, by such Person or any of its Subsidiaries; or (ii) in the case of a partnership, joint venture, association or other business entity, with respect to
which such Person or any of its Subsidiaries has the power to direct or cause the direction of the management and policies of such entity by contract or otherwise, or if in accordance with GAAP such entity is consolidated with such Person for
financial statement purposes. 
 “TIA” means the Trust Indenture Act of 1939 (15 U.S. Code Section 77aaa-77bbbb) as in effect
on the date of this Indenture (except as provided in Section 8.3). 
 “Trustee” means the party named as such in this
Indenture until a successor replaces it pursuant to this Indenture, and thereafter means the successor, and if at any time there is more than one such Person, “Trustee” as used with respect to the Securities of any Series shall mean
the Trustee with respect to Securities of that Series. 
 “U.S. Government Obligations” means direct non-callable obligations of, or non-callable obligations guaranteed by, the United States of America for the payment of which obligation or guarantee the full faith and credit
of the United States of America is pledged. 

  
 3 

 1.2. OTHER DEFINITIONS. 

The definitions of the following terms may be found in the sections indicated as follows: 

 

			
	 TERM
	  	 DEFINED IN SECTION

	“Bankruptcy Law”	  	6.1
	“Business Day”	  	10.7
	“Covenant Defeasance”	  	9.3
	“Custodian”	  	6.1
	“Event of Default”	  	6.1
	“Journal”	  	10.15
	“Judgment Currency”	  	10.16
	“Legal Defeasance”	  	9.2
	“Legal Holiday”	  	10.7
	“Market Exchange Rate”	  	10.15
	“New York Paying Agent”	  	2.4
	“Paying Agent”	  	2.4
	“Place of Payment”	  	10.7
	“Registrar”	  	2.4
	“Required Currency”	  	10.16
	“Service Agent”	  	2.4

 1.3. INCORPORATION BY REFERENCE OF TRUST INDENTURE ACT. 

Whenever this Indenture refers to a provision of the TIA, the portion of such provision required to be incorporated herein in order for this
Indenture to be qualified under the TIA is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: 

“Commission” means the SEC. 

“Indenture securities” means the Securities. 

“Indenture securityholder” means a Holder or Securityholder. 

“Indenture to be qualified” means this Indenture. 

“Indenture trustee” or “institutional trustee” means the Trustee. 

“Obligor on the indenture securities” means the Company or any other obligor on the Securities. 

All other terms used in this Indenture that are defined by the TIA, defined in the TIA by reference to another statute or defined by SEC
rule have the meanings therein assigned to them. 
 1.4. RULES OF CONSTRUCTION. 

Unless the context otherwise requires: 

(1) a term has the meaning assigned to it herein, whether defined expressly or by reference; 

(2) unless otherwise specified herein, all accounting terms used herein shall be interpreted, all accounting determinations hereunder shall be
made, and all financial statements required to be delivered hereunder shall be prepared in accordance with GAAP; 
 (3) “or” is
not exclusive; 
 (4) words in the singular include the plural, and in the plural include the singular; 

(5) words used herein implying any gender shall apply to each gender; 

  
 4 

 (6) the words “herein”, “hereof” and “hereunder” and other
words of similar import refer to this Indenture as a whole and not to any particular Article, Section or other subdivision; and 
 (7)
“$,” refers to Dollars, or such other money of the United States that at the time of payment is legal tender for payment of public and private debts. 

ARTICLE 2 – 

THE SECURITIES 
 2.1. ISSUABLE IN
SERIES. 
 The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is
$                ,                 ,
                . The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth in a Board
Resolution, a supplemental indenture or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time,
the Board Resolution, Officers’ Certificate or supplemental indenture may provide for the method by which specified terms (such as interest rate, Stated Maturity, record date or date from which interest shall accrue) are to be determined.
Securities may differ between Series in respect of any matters, PROVIDED, that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture. 

2.2. ESTABLISHMENT OF TERMS OF SERIES OF SECURITIES. 

At or prior to the issuance of any Securities within a Series, the following shall be established (as to the Series generally, in the case
of Subsection 2.2(1) and either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2(2) through 2.2(24)) by a Board Resolution, a supplemental indenture or an Officers’
Certificate, in each case, pursuant to authority granted under a Board Resolution: 
 (1) the title of the Series (which shall
distinguish the Securities of that particular Series from the Securities of any other Series); 
 (2) any limit upon the aggregate
principal amount of the Securities of the Series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other
Securities of the Series pursuant to Section 2.7, 2.8, 2.11, 3.6 or 8.5); 
 (3) the price or prices (expressed as a percentage of
the principal amount thereof) at which the Securities of the Series will be issued; 
 (4) the date or dates on which the principal of
the Securities of the Series is payable; 
 (5) the rate or rates (which may be fixed or variable) per annum or, if applicable, the
method used to determine such rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear interest, if any, the date or dates from which
such interest, if any, shall accrue, the date or dates on which such interest, if any, shall commence and be payable and any regular record date for the interest payable on any Interest Payment Date; 

(6) the place or places where the principal of, and interest and premium, if any, on, the Securities of the Series shall be payable, or
the method of such payment, if by wire transfer, mail or other means; 
 (7) if applicable, the period or periods within which, the price or
prices at which and the terms and conditions upon which the Securities of the Series may be redeemed, in whole or in part, at the option of the Company; 

(8) the obligation, if any, of the Company to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous
provisions or at the option of a Holder thereof, and the period or periods within which, the price or prices at which and the terms and conditions upon which Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant
to such obligation; 
 (9) the dates, if any, on which and the price or prices at which the Securities of the Series will be
repurchased by the Company at the option of the Holders thereof, and other detailed terms and provisions of such repurchase obligations; 

(10) if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities of the
Series shall be issuable; 
 (11) the forms of the Securities of the Series in bearer (if to be issued outside of the United
States of America) or fully registered form (and, if in fully registered form, whether the Securities will be issuable as Global Securities); 

  
 5 

 (12) if other than the principal amount thereof, the portion of the principal amount of the
Securities of the Series that shall be payable upon declaration of acceleration of the Maturity thereof pursuant to Section 6.2; 

(13) the currency of denomination of the Securities of the Series, which may be Dollars or any Foreign Currency, including, but not limited
to, the Euro, and, if such currency of denomination is a composite currency other than the Euro, the agency or organization, if any, responsible for overseeing such composite currency; 

(14) the designation of the currency, currencies or currency units in which payment of the principal of, and interest and premium, if any, on,
the Securities of the Series will be made; 
 (15) if payments of principal of, or interest or premium, if any, on, the Securities of
the Series are to be made in one or more currencies or currency units other than that or those in which such Securities are denominated, the manner in which the exchange rate with respect to such payments will be determined; 

(16) the manner in which the amounts of payment of principal of, or interest and premium, if any, on, the Securities of the Series will
be determined, if such amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; 

(17) the provisions, if any, relating to any collateral provided for the Securities of the Series; 

(18) any addition to or change in the covenants set forth in Articles 4 or 5 that applies to Securities of the Series; 

(19) any addition to or change in the Events of Default which applies to any Securities of the Series, any provision for the payment of
additional interest or liquidated damages in connection with any Event of Default, and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to
Section 6.2; 
 (20) the terms and conditions, if any, for conversion of the Securities into or exchange of the Securities for shares
of common stock, preferred stock, other debt securities, or warrants, subscription rights or units for common stock, preferred stock or other securities of any kind of the Company that apply to Securities of the Series; 

(21) any Trustees, depositories, interest rate calculation agents, exchange rate calculation agents or other agents with respect to Securities
of such Series if other than those appointed herein; 
 (22) the terms and conditions, if any, upon which the Securities shall be
subordinated in right of payment to other Indebtedness of the Company; 
 (23) if applicable, that the Securities of the Series, in whole or
any specified part, shall be defeasible pursuant to Article 9; and 
 (24) any other terms of the Securities of the Series (which
terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 8.1, but which may modify or delete any provision of this Indenture insofar as it applies to such Series). 

All Securities of any one Series need not be issued at the same time, and may be issued from time to time, consistent with the terms of
this Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, however, the authorized principal amount of any Series may not be increased to provide for issuances
of additional Securities of such Series, unless otherwise provided in such Board Resolution, supplemental indenture or Officers’ Certificate. 

2.3. EXECUTION AND AUTHENTICATION. 
 The
Securities shall be executed on behalf of the Company by two Officers of the Company or an Officer and an Assistant Secretary of the Company. Each such signature may be either manual or facsimile. The Company’s seal may be impressed, affixed,
imprinted or reproduced on the Securities and may be in facsimile form. 
 If an Officer whose signature is on a Security no longer holds
that office at the time the Security is authenticated, the Security shall nevertheless be valid. 
 A Security shall not be valid until
authenticated by the manual signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. The Trustee shall at any time, and from time to time,
authenticate Securities for original issue in the principal amount provided in the Board Resolution, supplemental indenture hereto or Officers’ Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize
authentication and delivery pursuant to oral or electronic instructions from the Company or its duly authorized agent or agents, which oral instructions shall be promptly confirmed in writing. Each Security shall be dated the date of its
authentication. 

  
 6 

 The aggregate principal amount of Securities of any Series outstanding at any time may
not exceed any limit upon the maximum principal amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.2, except as provided in
Section 2.8. 
 Prior to the issuance of Securities of any Series, the Trustee shall have received and (subject to Section 7.1)
shall be fully protected in relying on: (a) the Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of that Series or of Securities within that Series and the terms of
the Securities of that Series or of Securities within that Series, (b) an Officers’ Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying with Section 10.4. 

The Trustee shall have the right to decline to authenticate and deliver any Securities of any Series: (a) if the Trustee, being advised
in writing by outside counsel, determines that such action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or trustees, executive committee or a trust committee of directors and/or vice-presidents shall
reasonably determine that such action would expose the Trustee to personal liability, or cause it to have a conflict of interest with respect to Holders of any then outstanding Series of Securities. 

The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate
Securities whenever the Trustee may do so. Any appointment shall be evidenced by an instrument signed by an authorized officer of the Trustee, a copy of which shall be furnished to the Company. Each reference in this Indenture to authentication by
the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate of the Company. 

2.4. REGISTRAR AND PAYING AGENT. 

The Company shall maintain in each Place of Payment for any Series of Securities (i) an office or agency where such Securities may be
presented for registration of transfer or for exchange (“Registrar”), (ii) an office or agency where such Securities may be presented for payment (“Paying Agent”),and PROVIDED, that at the option of the Company payment of
interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the register for the Securities maintained by the Registrar), and (iii) an office or agency where notices and demands to or upon
the Company in respect of the Securities and this Indenture may be served (“Service Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Company may have one or more co-Registrars and Service Agents and one or more additional Paying Agents. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at
any time the Company shall fail to maintain any such required office, or to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee as set forth in
Section 10.2. The Company or any of its Subsidiaries may also act as Paying Agent. If the Company acts as Paying Agent, it shall segregate the money held by it for the payment of principal of, and interest and premium, if any, on, the
Securities and hold it as a separate trust fund. The Company may change any Paying Agent, Registrar, co-registrar, Service Agent or any other Agent without notice to any Securityholder. 

The Company may also from time to time designate one or more other offices or agencies where the Securities may be presented or surrendered
for any or all such purposes, and may from time to time rescind such designations; PROVIDED, HOWEVER, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in each Place of
Payment for Securities of any Series for such purposes. The Company hereby initially designates the Corporate Trust Office of the Trustee as such office of the Company. The Company shall give prompt written notice to the Trustee of such
designation or rescission, and of any change in the location of any such other office or agency. 
 The Company shall enter into an
appropriate agency agreement with any Registrar, Paying Agent or Service Agent not a party to this Indenture. The agreement shall implement the provisions of this Indenture that relate to such Agent. The Company shall notify the Trustee of the name
and address of any such Agent. If the Company fails to maintain a Registrar, Paying Agent, or Service Agent and demands, or fails to give the foregoing notice, the Trustee shall act as such. The Company hereby appoints the Trustee as the initial
Registrar, Paying Agent and Service Agent for each Series unless another Registrar, Paying Agent or Service Agent, as the case may be, is appointed prior to the time Securities of that Series are first issued. The Company designates, as
the New York Paying Agent, with offices at:                    . 

2.5. PAYING AGENT TO HOLD ASSETS IN TRUST. 

The Trustee as Paying Agent shall, and the Company shall require each Paying Agent other than the Trustee to agree in writing that each Paying
Agent shall, hold in trust for the benefit of the Holders of any Series of Securities or the Trustee all assets held by the Paying Agent for the payment of principal of, or interest or premium, if any, on, such Series of Securities
(whether such assets have been distributed to it by the Company or any other obligor on such Series of Securities), and the Company and the Paying Agent shall 

  
 7 

 
notify the Trustee in writing of any Default by the Company (or any other obligor on such Series of Securities) in making any such payment. The Company at any time may require a Paying Agent
to distribute all assets held by it to the Trustee and account for any assets disbursed, and the Trustee may, at any time during the continuance of any payment default with respect to any Series of Securities, upon written request to a Paying
Agent, require such Paying Agent to distribute all assets held by it to the Trustee and to account for any assets distributed. Upon distribution to the Trustee of all assets that shall have been delivered by the Company to the Paying Agent, the
Paying Agent shall have no further liability for such assets. 
 2.6. SECURITYHOLDER LISTS. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of
Securityholders of each Series of Securities. If the Trustee is not the Registrar, the Company shall furnish to the Trustee as of each regular record date for the payment of interest on the Securities of a Series and before each related
Interest Payment Date, and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Securityholders of each Series of Securities. 

2.7. TRANSFER AND EXCHANGE. 
 When
Securities of a Series are presented by the Holder to the Registrar with a request to register the transfer thereof, the Registrar shall register the transfer as requested if the requirements of applicable law are met, and when such Securities
of a Series are presented to the Registrar with a request to exchange them for an equal principal amount of other authorized denominations of Securities of the same Series, the Registrar shall make the exchange as requested. To permit transfers
and exchanges, upon surrender of any Security for registration of transfer at the office or agency maintained pursuant to Section 2.4, the Company shall execute and the Trustee shall authenticate Securities at the Registrar’s request. 

If Securities are issued as Global Securities, the provisions of Section 2.15 shall apply. 

All Securities issued upon any registration of transfer or exchange of Securities shall be the valid obligations of the Company, evidencing
the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange. 

Every Security presented or surrendered for registration of transfer or for exchange shall (if so required by the Company or the Registrar or
a co-registrar) be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar or a co-registrar, duly
executed by the Holder thereof or his attorney duly authorized in writing. 
 Any exchange or transfer shall be without charge, except that
the Company may require payment by the Holder of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation to a transfer or exchange, but this provision shall not apply to any exchange pursuant to
Section 2.11, 3.6 or 8.5. The Trustee shall not be required to register transfers of Securities of any Series, or to exchange Securities of any Series, for a period of 15 days before the record date for selection for redemption of such
Securities. The Trustee shall not be required to exchange or register transfers of Securities of any Series called or being called for redemption in whole or in part, except the unredeemed portion of such Security being redeemed in part. 

2.8. REPLACEMENT SECURITIES. 
 If a
mutilated Security is surrendered to the Trustee, or if the Holder of a Security presents evidence to the satisfaction of the Company and the Trustee that the Security has been lost, destroyed or wrongfully taken, the Company shall issue and the
Trustee shall authenticate a replacement Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding. An indemnity bond may be required by the Company or the Trustee that is
sufficient in the reasonable judgment of the Company or the Trustee, as the case may be, to protect the Company, the Trustee or any Agent from any loss which any of them may suffer if a Security is replaced. The Company may charge such Holder for
the Company’s out-of-pocket expenses in replacing a Security, including the fees and expenses of the Trustee. Every replacement Security shall constitute an
original additional obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled to all the benefits of this Indenture equally and proportionately with any and all
other Securities of that Series duly issued hereunder. 
 2.9. OUTSTANDING SECURITIES. 

Securities outstanding at any time are all Securities authenticated by the Trustee, except for those canceled by it, those delivered to it for
cancellation and those described in this Section 2.9 as not outstanding. 

  
 8 

 If a Security is replaced pursuant to Section 2.8 (other than a mutilated Security
surrendered for replacement), it ceases to be outstanding until the Company and the Trustee receive proof satisfactory to each of them that the replaced Security is held by a bona fide purchaser. A mutilated Security ceases to be outstanding upon
surrender of such Security and replacement thereof pursuant to Section 2.8. 
 If a Paying Agent holds on a Redemption Date or the
Stated Maturity money sufficient to pay the principal of, premium, if any, and accrued interest on, Securities payable on that date, and is not prohibited from paying such money to the Holders thereof pursuant to the terms of this Indenture
(PROVIDED, that if such Securities are to be redeemed, notice of such redemption has been duly given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made), then on and after that date and upon payment of such
money to the Holder, such Securities will be cancelled and cease to be outstanding and interest on them ceases to accrue. 
 A Security does
not cease to be outstanding solely because the Company or an Affiliate holds the Security. 
 2.10. WHEN TREASURY SECURITIES DISREGARDED;
DETERMINATION OF HOLDERS’ ACTION. 
 In determining whether the Holders of the required aggregate principal amount of the Securities
of any Series have concurred in any direction, waiver or consent, the Securities of any Series owned by the Company or any other obligor on such Securities, or by any Affiliate of any of them, shall be disregarded, except that for the
purposes of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities of such Series which the Trustee actually knows are so owned shall be so disregarded. Securities of such
Series so owned which have been pledged in good faith shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to the Securities of such Series and that the
pledgee is not the Company or any other obligor on the Securities of such Series, or an Affiliate of any of them. 
 2.11. TEMPORARY SECURITIES.

 Until definitive Securities are ready for delivery, the Company may prepare and execute, and the Trustee shall authenticate, temporary
Securities. Temporary Securities shall be substantially in the form, and shall carry all rights, of definitive Securities, but may have variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the
Company shall prepare and execute, and the Trustee shall authenticate, definitive Securities in exchange for temporary Securities without charge to the Holder. 

2.12. CANCELLATION. 
 All Securities
surrendered for payment, redemption or registration of transfer or exchange, or for credit against any sinking fund payment, shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee for cancellation. The Company may at
any time deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and may deliver to the Trustee (or to any other Person for delivery to the
Trustee) for cancellation any Securities previously authenticated hereunder which the Company has not issued and sold. The Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered to them for transfer, exchange or
payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent, and no one else, shall cancel, and at the written request of the Company shall dispose of, all Securities surrendered for transfer, exchange, payment or
cancellation. If the Company shall acquire any of the Securities, such acquisition shall not operate as a redemption or satisfaction of the Indebtedness represented by such Securities unless and until the same are surrendered to the Trustee for
cancellation pursuant to this Section 2.12. No Securities shall be authenticated in lieu of or in exchange for any Securities cancelled as provided in this Section 2.12, except as expressly permitted by this Indenture. 

2.13. PAYMENT OF INTEREST; DEFAULTED INTEREST; COMPUTATION OF INTEREST. 

Except as otherwise provided as contemplated by Section 2.2 with respect to any Series of Securities, interest on any Security which
is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Security is registered at the close of business on the regular record date for such interest, as provided in the
Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the terms of such Series. 
 If the Company
defaults in a payment of interest on the Securities, it shall pay the defaulted amounts, plus any interest payable on defaulted amounts pursuant to Section 4.1, to the Persons who are Securityholders on a subsequent special record date, which
date shall be the 15th day next preceding the date fixed by the Company for the payment of defaulted interest, or the next succeeding Business Day if such date is not a Business Day. At least 15 days before the special record date, the Company
shall mail or cause to be mailed to each Securityholder, with a copy to the Trustee, a notice that states the special record date, the payment date and the amount of defaulted interest, and interest payable on such defaulted interest, if any, to be
paid. 

  
 9 

 Except as otherwise specified as contemplated by Section 2.2 for Securities of any
Series, interest on the Securities of each Series shall be computed on the basis of a 360-day year of twelve 30-day months. 

2.14. CUSIP NUMBER. 
 The Company in
issuing the Securities may use one or more “CUSIP” numbers, and, if the Company does so, the Trustee shall use the CUSIP number(s) in notices of redemption or exchange as a convenience to Holders, PROVIDED, that any such notice may
state that no representation is made as to the correctness or accuracy of the CUSIP number(s) printed in the notice or on the Securities, and that reliance may be placed only on the other identification numbers printed on the Securities, and
that any such redemption or exchange shall not be affected by any defect in or omission of any such numbers. 
 2.15. PROVISIONS FOR GLOBAL
SECURITIES. 
 (a) A Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall establish whether the
Securities of a Series shall be issued in whole or in part in the form of one or more Global Securities, and the Depository for such Global Securities or Securities. 

(b) Notwithstanding any provisions to the contrary contained in Section 2.7 and in addition thereto, if, and only if the Depository
(i) at any time is unwilling or unable to continue as Depository for such Global Security or ceases to be a clearing agency registered under the Exchange Act and (ii) a successor Depository is not appointed by the Company within
90 days after the date the Company is so informed in writing or becomes aware of the same, the Company promptly will execute and deliver to the Trustee definitive Securities, and the Trustee, upon receipt of a Company Request for the
authentication and delivery of such definitive Securities (which the Company will promptly execute and deliver to the Trustee) and an Officers’ Certificate to the effect that such Global Security shall be so exchangeable, will authenticate and
deliver definitive Securities, without charge, registered in such names and in such authorized denominations as the Depository shall direct in writing (pursuant to instructions from its direct and indirect participants or otherwise) in an aggregate
principal amount equal to the principal amount of the Global Security with like tenor and terms. Upon the exchange of a Global Security for definitive Securities, such Global Security shall be canceled by the Trustee. Unless and until it is
exchanged in whole or in part for definitive Securities, as provided in this Section 2.15(b), a Global Security may not be transferred except as a whole by the Depository with respect to such Global Security to a nominee of such Depository, by
a nominee of such Depository to such Depository or another nominee of such Depository or by the Depository or any such nominee to a successor Depository or a nominee of such a successor Depository. 

(c) Any Global Security issued hereunder shall bear a legend in substantially the following form: 

“This Security is a Global Security within the meaning of the Indenture hereinafter referred to, and is registered in the name of the
Depository or a nominee of the Depository. This Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the limited circumstances described in the Indenture, and may not be
transferred except as a whole by the Depository to a nominee of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of
such a successor Depository.” 
 (d) The Depository, as a Holder, may appoint agents and otherwise authorize participants to give or
take any request, demand, authorization, direction, notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture. 

(e) Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by Section 2.2, payment of the
principal of, and interest and premium, if any, on, any Global Security shall be made to the Depository or its nominee in its capacity as the Holder thereof. 

(f) Except as provided in Section 2.15(e) above, the Company, the Trustee and any Agent shall treat a Person as the Holder of such
principal amount of outstanding Securities of any Series represented by a Global Security as shall be specified in a written statement of the Depository (which may be in the form of a participants’ list for such Series) with respect to
such Global Security, for purposes of obtaining any consents, declarations, waivers or directions required to be given by the Holders pursuant to this Indenture, PROVIDED, that until the Trustee is so provided with a written statement, it may treat
the Depository or any other Person in whose name a Global Security is registered as the owner of such Global Security for the purpose of receiving payment of the principal of, and any premium and (subject to Section 2.13) any interest on, such
Global Security and for all other purposes whatsoever, and none of the Company, the Trustee or any agent of the Company or the Trustee shall be affected by notice to the contrary. 

  
 10 

 2.16. PERSONS DEEMED OWNERS. 

Prior to due presentment of a Security for registration of transfer, the Company, the Trustee, the Registrar and any agent of the Company, the
Registrar or the Trustee may treat the Person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment of the principal of, and any premium and (subject to Section 2.13) any interest on, such
Security and for all other purposes whatsoever, and none of the Company, the Trustee, the Registrar or any agent of the Company, the Trustee or the Registrar shall be affected by notice to the contrary. 

ARTICLE 3 – 

REDEMPTION 
 3.1. NOTICES TO
TRUSTEE. 
 The Company may, with respect to any Series of Securities, reserve the right to redeem and pay the Series of
Securities, or may covenant to redeem and pay the Series of Securities or any part thereof, prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities or the related Board Resolution, supplemental
indenture or Officers’ Certificate. If a Series of Securities is redeemable and the Company elects to redeem all or part of such Series of Securities, it shall notify the Trustee of the Redemption Date and the principal amount of
Securities to be redeemed at least 45 days (unless a shorter notice shall be satisfactory to the Trustee) before the Redemption Date. Any such notice may be canceled at any time prior to notice of such redemption being mailed to any Holder, and
shall thereby be void and of no effect. 
 3.2. SELECTION BY TRUSTEE OF SECURITIES TO BE REDEEMED. 

Unless otherwise indicated for a particular Series of Securities by a Board Resolution, a supplemental indenture or an Officers’
Certificate, if fewer than all of the Securities of a Series are to be redeemed, the Trustee shall select the Securities of a Series to be redeemed pro rata, by lot or by any other method that the Trustee considers fair and appropriate
(unless the Company specifically directs the Trustee otherwise) and, if such Securities are listed on any securities exchange, by a method that complies with the requirements of such exchange. 

The Trustee shall make the selection from Securities of a Series outstanding and not previously called for redemption, and shall promptly
notify the Company in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount thereof to be redeemed at least 35 but not more than 60 days before the Redemption
Date. Securities of a Series in denominations of $1,000 may be redeemed only in whole. The Trustee may select for redemption portions of the principal of Securities of a Series that have denominations larger than $1,000. Securities of a
Series and portions of them it selects shall be in amounts of $1,000 or, with respect to Securities of any Series issuable in other denominations pursuant to Section 2.2(10), the minimum principal denomination for each Series and
integral multiples thereof. Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. 

3.3. NOTICE OF REDEMPTION. 
 Unless
otherwise indicated for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least 30 days, and no more than 60 days, before a Redemption Date, the Company shall mail, or cause
to be mailed, a notice of redemption by first-class mail to each Holder of Securities to be redeemed at his or her last address as the same appears on the registry books maintained by the Registrar. The notice shall identify the Securities to be
redeemed and shall state: 
 (1) the Redemption Date; 

(2) the redemption price, and that such redemption price shall become due and payable on the Redemption Date; 

(3) if any Security of a Series is being redeemed in part, the portion of the principal amount of such Security of a Series to be
redeemed and that, after the Redemption Date and upon surrender of such Security of a Series, a new Security or Securities in principal amount equal to the unredeemed portion will be issued; 

(4) the name and address of the Paying Agent; 

(5) that Securities of a Series called for redemption must be surrendered to the Paying Agent to collect the redemption price, and the
place or places where each such Security is to be surrendered for such payment; 
 (6) that, unless the Company defaults in making the
redemption payment, interest on the Securities of a Series called for redemption ceases to accrue on the Redemption Date, and the only remaining right of the Holders of such Securities is to receive payment of the redemption price upon
surrender to the Paying Agent of the Securities redeemed; 

  
 11 

 (7) if fewer than all of the Securities of a Series are to be redeemed, the
identification of the particular Securities of a Series (or portion thereof) to be redeemed, as well as the aggregate principal amount of Securities of a Series to be redeemed and the aggregate principal amount of Securities of a
Series to be outstanding after such partial redemption. 
 (8) the CUSIP number, if any, printed on the Securities being redeemed; and

 (9) that no representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the
Securities. 
 At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name and at the
Company’s sole expense. 
 3.4. EFFECT OF NOTICE OF REDEMPTION. 

Once the notice of redemption described in Section 3.3 is mailed, Securities of a Series called for redemption become due and payable
on the Redemption Date and at the redemption price, plus interest, if any, accrued to the Redemption Date. Upon surrender to the Trustee or Paying Agent, such Securities of a Series shall be paid at the redemption price, plus accrued interest,
if any, to the Redemption Date; PROVIDED, that if the Redemption Date is after a regular interest payment record date and on or prior to the next Interest Payment Date, the accrued interest shall be payable to the Holder of the redeemed Securities
registered on the relevant record date, as specified by the Company in the notice to the Trustee pursuant to Section 3.1. 
 3.5. DEPOSIT OF
REDEMPTION PRICE. 
 On or prior to the Redemption Date (but no later than 11:00 A.M. Eastern Time on such date), the Company shall
deposit with the Paying Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date other than Securities or portions thereof called for redemption on that date which have been
delivered by the Company to the Trustee for cancellation. 
 On and after any Redemption Date, if money sufficient to pay the redemption
price of, and accrued interest on, Securities called for redemption shall have been made available in accordance with the preceding paragraph and the Company and the Paying Agent are not prohibited from paying such moneys to Holders, the Securities
called for redemption will cease to accrue interest and the only right of the Holders of such Securities will be to receive payment of the redemption price of and, subject to the proviso in Section 3.4, accrued and unpaid interest on such
Securities to the Redemption Date. If any Security called for redemption shall not be so paid, interest will be paid, from the Redemption Date until such redemption payment is made, on the unpaid principal of the Security and any interest or
premium, if any, not paid on such unpaid principal, in each case, at the rate and in the manner provided in the Securities. 
 3.6. SECURITIES
REDEEMED IN PART. 
 Upon surrender of a Security of a Series that is redeemed in part, the Company shall execute, and the Trustee
shall authenticate, for a Holder a new Security of the same Series equal in principal amount to the unredeemed portion of the Security surrendered. 

ARTICLE 4 – 

COVENANTS 
 4.1. PAYMENT OF
SECURITIES. 
 The Company shall pay the principal of, and interest and premium, if any, on, each Series of Securities on the dates
and in the manner provided in such Securities and this Indenture. 
 An installment of principal or interest shall be considered paid on the
date it is due if the Trustee or Paying Agent holds on that date money designated for and sufficient to pay such installment and is not prohibited from paying such money to the Holders pursuant to the terms of this Indenture or otherwise. 

The Company shall pay interest on overdue principal, and overdue interest, to the extent lawful, at the rate specified in the Series of
Securities. 

  
 12 

 4.2. SEC REPORTS. 

The Company will deliver to the Trustee within 15 days after the filing of the same with the SEC, copies of the quarterly and annual
reports and of the information, documents and other reports, if any, which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act; PROVIDED, HOWEVER, that each such report or document will be
deemed to be so delivered to the Trustee if the Company files such report or document with the SEC through the SEC’s EDGAR database no later than the time such report or document is required to be filed with the SEC pursuant to the Exchange
Act. Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file with the SEC, to the extent permitted, and provide the Trustee with, such quarterly
and annual reports and such information, documents and other reports specified in Sections 13 and 15(d) of the Exchange Act. The Company will also comply with the other provisions of TIA Section 314(a). 

4.3. WAIVER OF STAY, EXTENSION OR USURY LAWS. 

The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead (as a defense or otherwise)
or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension, usury or other law which would prohibit or forgive the Company from paying all or any portion of the principal of, and/or interest and premium, if any, on,
the Securities as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture; and the Company hereby expressly waives (to the extent that they may lawfully do
so) all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such law had
been enacted. 
 4.4. COMPLIANCE CERTIFICATE. 

(a) The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Company, an Officers’
Certificate which complies with TIA Section 314(a)(4) stating that a review of the activities of the Company and its Subsidiaries during such fiscal year has been made under the supervision of the signing Officers with a view to
determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge the Company has kept,
observed, performed and fulfilled each and every covenant contained in this Indenture and that there is no default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default shall
have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has occurred
and remains in existence by reason of which payments on account of the principal of, or interest or premium, if any, on, the Securities is prohibited, or if such event has occurred, a description of the event and what action the Company is taking or
proposes to take with respect thereto. 
 (b)(i) If any Default or Event of Default has occurred and is continuing or (ii) if any
Holder seeks to exercise any remedy hereunder with respect to a claimed Default under this Indenture or the Securities, within five Business Days after the Company becoming aware of such occurrence the Company shall deliver to the Trustee an
Officers’ Certificate specifying such event, notice or other action and what action the Company is taking or proposes to take with respect thereto. 

4.5. CORPORATE EXISTENCE. 
 Subject
to Article 5, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, in accordance with the organizational documents (as the same may be amended from time to time) of
the Company and the rights (charter and statutory), licenses and franchises of the Company; PROVIDED, HOWEVER, that the Company shall not be required to preserve any such right, license or franchise, or its corporate existence, if the Board of
Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and that the loss thereof is not adverse in any material respect to the Holders. 

ARTICLE 5 – 

SUCCESSOR CORPORATION 
 5.1. LIMITATION
ON CONSOLIDATION, MERGER AND SALE OF ASSETS. 
 (a) The Company will not, in any transaction or series of transactions, merge or
consolidate with or into, or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially all of its properties and assets (as an entirety or substantially as an entirety in one transaction or a series of related transactions),
to any Person or Persons, unless at the time of and after giving effect thereto (i) either (A) if the transaction or series of transactions is a merger or consolidation, the Company shall be the surviving Person of such merger or
consolidation, or (B) the Person formed by such consolidation or into which the Company is merged or to which the 

  
 13 

 
properties and assets of the Company are transferred (any such surviving Person or transferee Person being the “Surviving Entity”) shall be a corporation organized and existing under
the laws of the United States of America, any state thereof or the District of Columbia, or a corporation or comparable legal entity organized under the laws of a foreign jurisdiction and shall expressly assume by a supplemental indenture executed
and delivered to the Trustee, in form reasonably satisfactory to the Trustee, all of the obligations of the Company (including, without limitation, the obligation to pay the principal of, and premium and interest, if any, on, the Securities and the
performance of the other covenants) under the Securities of each Series and this Indenture, and in each case, this Indenture shall remain in full force and effect; and (ii) immediately before and immediately after giving effect to such
transaction or series of transactions on a pro forma basis (including, without limitation, any Indebtedness incurred or anticipated to be incurred in connection with or in respect of such transaction or series of transactions), no Default or Event
of Default shall have occurred and be continuing. 
 (b) In connection with any consolidation, merger or transfer of assets contemplated by
this Section 5.1, the Company shall deliver, or cause to be delivered, to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation,
merger or transfer, and the supplemental indenture in respect thereto, 
 comply with this Section 5.1, and that all conditions precedent herein
provided for relating to such transaction or transactions have been complied with. 
 5.2. SUCCESSOR PERSON SUBSTITUTED. 

Upon any consolidation, merger or transfer of all or substantially all of the assets of the Company in accordance with Section 5.1 above,
the successor corporation formed by such consolidation, or into which the Company is merged or to which such transfer is made, shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with
the same effect as if such successor corporation had been named as the Company herein, and thereafter (except with respect to any such transfer which is a lease) the predecessor corporation shall be relieved of all obligations and covenants under
this Indenture and the Securities. 
 ARTICLE 6 – 

DEFAULTS AND REMEDIES 
 6.1. EVENTS
OF DEFAULT. 
 An “Event of Default,” wherever used herein with respect to Securities of any Series, means any one of the
following events, unless in the establishing Board Resolution, supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said Event of Default: 

(1) there is a default in the payment of any principal of, or premium, if any, on, the Securities when the same becomes due and payable at
Maturity, upon acceleration, redemption or otherwise; 
 (2) there is a default in the payment of any interest on any Security of a
Series when the same becomes due and payable, and the Default continues for a period of 30 days; 
 (3) the Company defaults in
the observance or performance of any other covenant in the Securities of a Series or in this Indenture for 60 days after written notice from the Trustee or the Holders of not less than 25% in the aggregate principal amount of the
Securities of such Series then outstanding, which notice must specify the Default, demand that it be remedied and state that the notice is a “Notice of Default”; 

(4) the Company or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 

(A) commences a voluntary case, 

(B) consents to the entry of an order for relief against it in an involuntary case, 

(C) consents to the appointment of a Custodian of it or for all or substantially all of its property, 

(D) makes a general assignment for the benefit of its creditors, or 

(E) generally is not paying its debts as they become due; 

(5) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A) is for relief against the Company or any Significant Subsidiary in an involuntary case; 

(B) appoints a Custodian of the Company or any Significant Subsidiary, or for all or substantially all of the property of
the Company or any Significant Subsidiary; or 
 (C) orders the liquidation of the Company or any Significant
Subsidiary, and the order or decree remains unstayed and in effect for 90 consecutive days; or 
 (6) any other Event of Default provided
with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, in accordance with Section 2.2(19). 

  
 14 

 The term “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal or
state law for the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

The Trustee may withhold notice of any Default (except in the payment of the principal of, or interest or premium, if any, on, the Securities)
to the Holders of the Securities of any Series in accordance with Section 7.5. When a Default is cured, it ceases to exist. 
 6.2.
ACCELERATION. 
 If an Event of Default with respect to Securities of any Series at the time outstanding (other than an Event of
Default arising under Section 6.1(4) or (5)) occurs and is continuing, the Trustee by written notice to the Company, or the Holders of not less than 25% in aggregate principal amount of the Securities of that Series then
outstanding by written notice to the Company and the Trustee, may declare that the entire principal amount of all the Securities of that Series then outstanding plus accrued and unpaid interest to the date of acceleration are immediately due
and payable, in which case such amounts shall become immediately due and payable; PROVIDED, HOWEVER, that after such acceleration but before a judgment or decree based on such acceleration is obtained by the Trustee, the Holders of a majority in
aggregate principal amount of the outstanding Securities of that Series may rescind and annul such acceleration and its consequences if (i) all existing Events of Default, other than the nonpayment of accelerated principal, interest or
premium, if any, that has become due solely because of the acceleration, have been cured or waived, (ii) to the extent the payment of such interest is lawful, interest on overdue installments of interest and overdue principal, which has become
due otherwise than by such declaration of acceleration, has been paid and (iii) the rescission would not conflict with any judgment or decree. No such rescission shall affect any subsequent Default or impair any right consequent thereto. In
case an Event of Default specified in Section 6.1(4) or (5) with respect to the Company occurs, such principal, premium, if any, and interest amount with respect to all of the Securities of that Series shall be due and payable
immediately without any declaration or other act on the part of the Trustee or the Holders of the Securities of that Series. 
 6.3. REMEDIES. 

If an Event of Default with respect to Securities of any Series at the time outstanding occurs and is continuing, the Trustee may pursue
any available remedy by proceeding at law or in equity to collect the payment of the principal of, or interest and premium, if any, on, the Securities of that Series, or to enforce the performance of any provision of the Securities of that
Series or this Indenture. 
 The Trustee may maintain a proceeding even if it does not possess any of the Securities of that
Series or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver
of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All available remedies are cumulative to the extent permitted by law. 

6.4. WAIVER OF PAST DEFAULTS AND EVENTS OF DEFAULT. 

Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any Series then outstanding
have the right to waive any existing Default or Event of Default with respect to such Series or compliance with any provision of this Indenture (with respect to such Series) or the Securities of such Series. Upon any such waiver, such Default
with respect to such Series shall cease to exist, and any Event of Default with respect to such Series arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any
subsequent or other Default or Event of Default or impair any right consequent thereto. This Section 6.4 shall be in lieu of TIA Section 316(a)(1)(B), and TIA Section 316(a)(1)(B) is hereby expressly excluded from this Indenture
and Section as permitted by the TIA. 
 6.5. CONTROL BY MAJORITY. 

Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any Series then outstanding
may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee by this Indenture with respect to such Series. The Trustee, however, may refuse to
follow any direction that conflicts with law or this Indenture, or that the Trustee determines may be unduly prejudicial to the rights of another Securityholder, or that may involve the Trustee in personal liability; PROVIDED, that the Trustee may
take any other action deemed proper by the Trustee which is not inconsistent with such direction. This Section 6.5 shall be in lieu of TIA Section 316(a)(1)(A), and TIA Section 316(a)(1)(A) is hereby expressly excluded from this
Indenture and Section as permitted by the TIA. 

  
 15 

 6.6. LIMITATION ON SUITS. 

Subject to Section 6.7, a Securityholder may not institute any proceeding or pursue any remedy with respect to this Indenture or the
Securities of a Series unless: 
 (1) the Holder gives to the Trustee written notice of a continuing Event of Default with respect to
the Securities of that Series; 
 (2) the Holders of at least 25% in aggregate principal amount of the Securities of such Series then
outstanding make a written request to the Trustee to pursue the remedy; 
 (3) such Holder or Holders offer to the Trustee indemnity
reasonably satisfactory to the Trustee against any loss, liability or expense to be incurred in compliance with such request; 
 (4) the
Trustee does not comply with the request within 60 days after receipt of the request and the offer of indemnity; and 
 (5) no
direction inconsistent with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in aggregate principal amount of the Securities of such Series then
outstanding. 
 A Securityholder may not use this Indenture to prejudice the rights of another Securityholder, or to obtain a preference or
priority over another Securityholder. 
 6.7. RIGHTS OF HOLDERS TO RECEIVE PAYMENT. 

Notwithstanding any other provision of this Indenture, the right of any Holder of a Security of a Series to receive payment of the
principal of, and interest and premium, if any, on, the Security of such Series on or after the respective due dates expressed in the Security of such Series, or to bring suit for the enforcement of any such payment on or after such respective
dates, is absolute and unconditional, and shall not be impaired or affected without the consent of the Holder. 
 6.8. COLLECTION SUIT BY TRUSTEE.

 If an Event of Default in payment of principal, interest or premium, if any, specified in Section 6.1(1) or (2) with
respect to Securities of any Series at the time outstanding occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company (or any other obligor on the Securities of that
Series) for the whole amount of unpaid principal and premium, if any, and accrued interest remaining unpaid, together with interest on overdue principal and premium, if any, and, to the extent that payment of such interest is lawful, interest on
overdue installments of interest, in each case at the rate then borne by the Securities of that Series, and such further amounts as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and counsel, as set forth in Section 7.7. 
 6.9. TRUSTEE MAY FILE PROOFS OF CLAIM.

 The Trustee may file such proofs of claim and other papers or documents, and take other actions (including sitting on a committee of
creditors), as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Securityholders
allowed in any judicial proceedings relative to the Company (or any other obligor on the Securities), any of their respective creditors or any of their respective property, and the Trustee shall be entitled and empowered to collect and receive any
monies or other property payable or deliverable on any such claims, and to distribute the same after deduction of its charges and expenses to the extent that any such charges and expenses are not paid out of the estate in any such proceedings, and
any custodian in any such judicial proceeding is hereby authorized by each Securityholder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Securityholders, to pay to
the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.7. 

Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to, or accept or adopt on behalf of any
Securityholder, any plan of reorganization, arrangement, adjustment or composition affecting the Securities of a Series or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Securityholder in
any such proceedings. 

  
 16 

 6.10. PRIORITIES. 

If the Trustee collects any money pursuant to this Article 6, it shall pay out the money in the following order: 

FIRST: to the Trustee for amounts due under Section 7.7; 

SECOND: to Securityholders for amounts then due and unpaid for the principal of, and interest and premium, if any, on, the Securities in
respect of which, or for the benefit of which, such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities; for principal and any premium and interest, respectively;
and 
 THIRD: to the Company. 

The Trustee may fix a record date and payment date for any payment to Securityholders pursuant to this Section 6.10. At least
15 days before such record date, the Trustee shall mail to each Securityholder a notice that states the record date, the payment date and amount to be paid. 

6.11. UNDERTAKING FOR COSTS. 
 In any
suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an
undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or
defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in principal amount of the Securities of a Series then
outstanding. 
 ARTICLE 7 – 

TRUSTEE 
 7.1. DUTIES OF TRUSTEE.

 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the rights and powers vested in it by
this Indenture and use the same degree of care and skill in their exercise as a prudent Person would exercise or use under the same circumstances in the conduct of his own affairs. 

(b) Except during the continuance of an Event of Default: 

(1) The Trustee need perform only those duties that are specifically set forth in this Indenture, and no covenants or obligations shall be
implied in this Indenture against the Trustee. 
 (2) In the absence of bad faith on its part, the Trustee may conclusively rely, as to the
truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but, in the case of any such certificates or opinions which
by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture. 

(c) The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful
misconduct, except that: 
 (1) This paragraph does not limit the effect of paragraph (b) of this Section 7.1. 

(2) The Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the
Trustee was negligent in ascertaining the pertinent facts. 
 (3) The Trustee shall not be liable with respect to any action it takes or
omits to take in good faith in accordance with a direction received by it pursuant to Sections 6.2 and 6.5. 
 (d) No provision of this
Indenture shall require the Trustee to expend or risk its own funds, or otherwise incur any financial liability, in the performance of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or
adequate indemnity satisfactory to it against such risk or liability is not reasonably assured to it. 
 (e) Whether or not therein
expressly so provided, paragraphs (a), (b), (c) and (d) of this Section 7.1 shall govern every provision of this Indenture that in any way relates to the Trustee. 

  
 17 

 (f) The Trustee and Paying Agent shall not be liable for interest on any money received by
either of them, except as the Trustee and Paying Agent may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by the law. 

(g) The Paying Agent, the Registrar and any authenticating agent shall be entitled to the protections, immunities and standard of care set
forth in paragraphs (a), (b), (c), (d) and (f) of this Section 7.1 and in Section 7.2 with respect to the Trustee. 
 7.2. RIGHTS OF
TRUSTEE. 
 (a) Subject to Section 7.1: 

(1) The Trustee may rely on, and shall be protected in acting or refraining from acting upon, any document reasonably believed by it to be
genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document. 

(2) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel, or both, which
shall conform to the provisions of Section 10.5. The Trustee shall be protected and shall not be liable for any action it takes or omits to take in good faith in reliance on such certificate or opinion. 

(3) The Trustee may act through agents and attorneys, and shall not be responsible for the misconduct or negligence of any agent appointed by
it with due care. 
 (4) The Trustee shall not be liable for any action it takes or omits to take in good faith which it reasonably believes
to be authorized or within its rights or powers. 
 (5) The Trustee may consult with counsel reasonably acceptable to the Trustee, which may
be counsel to the Company, and the advice or opinion of such counsel as to matters of law shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered by it hereunder in good faith and in
accordance with the advice or opinion of such counsel. 
 (6) The Trustee shall be under no obligation to exercise any of the rights or
powers vested in it by this Indenture at the request, order or direction of any of the Holders pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs,
expenses and liabilities which may be incurred therein or thereby. 
 (7) The Trustee shall not be deemed to have knowledge of any fact or
matter (including, without limitation, a Default or Event of Default) unless such fact or matter is known to a Responsible Officer of the Trustee. 

(8) Unless otherwise expressly provided herein or in the Securities of a Series or the related Board Resolution, supplemental indenture
or Officers’ Certificate, the Trustee shall not have any responsibility with respect to reports, notices, certificates or other documents filed with it hereunder, except to make them available for inspection, at reasonable times, by
Securityholders, it being understood that delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information
contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (except as set forth in Section 4.4). 

7.3. INDIVIDUAL RIGHTS OF TRUSTEE. 
 The
Trustee in its individual or any other capacity may become the owner or pledgee of Securities, and may make loans to, accept deposits from, perform services for or otherwise deal with the Company, or any Affiliate thereof, with the same rights it
would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee, however, shall be subject to Sections 7.10 and 7.11. 

7.4. TRUSTEE’S DISCLAIMER. 
 The
Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities (except that the Trustee represents that it is duly authorized to execute and deliver this Indenture and authenticate the Securities and perform its
obligations hereunder), and the Trustee shall not be accountable for the Company’s use of the proceeds from the sale of Securities or any money paid to the Company pursuant to the terms of this Indenture, and the Trustee shall not be
responsible for any statement in the Securities other than its certificates of authentication. 

  
 18 

 7.5. NOTICE OF DEFAULT. 

If a Default or an Event of Default occurs and is continuing with respect to the Securities of any Series, and if it is known to the Trustee,
the Trustee shall mail to each Securityholder of the Securities of that Series notice of the Default or the Event of Default, as the case may be, within 90 days after it occurs or, if later, after a Responsible Officer of the Trustee has
knowledge of such Default or Event of Default (except if such Default or Event of Default has been validly cured or waived before the giving of such notice). Except in the case of a Default or an Event of Default in payment of the principal of, or
interest or premium, if any, on, any Security of any Series, the Trustee may withhold the notice if and so long as the Board of Directors of the Trustee, the executive committee or any trust committee of such board and/or its Responsible Officers in
good faith determine(s) that withholding the notice is in the interests of the Securityholders of that Series. 
 7.6. REPORTS BY TRUSTEE TO
HOLDERS. 
 If and to the extent required by the TIA, within 60 days after April 1 of each year, commencing the April 1
following the date of this Indenture, the Trustee shall mail to each Securityholder a brief report dated as of such April 1 that complies with TIA Section 313(a). The Trustee also shall comply with TIA Sections 313(b) and 313(c). 

A copy of each report at the time of its mailing to Securityholders shall be filed with the SEC and any stock exchange on which the Securities
of that Series are listed. The Company shall promptly notify the Trustee when the Securities of any Series are listed on any stock exchange or any delisting thereof, and the Trustee shall comply with TIA Section 313(d). 

7.7. COMPENSATION AND INDEMNITY. 

The Company shall pay to the Trustee from time to time reasonable compensation for its services. The Trustee’s compensation shall not be
limited by any provision of law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee within 45 days after receipt of request for all reasonable
out-of-pocket disbursements and expenses incurred or made by it in connection with its duties under this Indenture, including the reasonable compensation, disbursements
and expenses of the Trustee’s agents and counsel. 
 The Company shall indemnify the Trustee for, and hold it harmless against, any and
all loss or liability incurred by it in connection with the acceptance or performance of its duties under this Indenture including the reasonable costs and expenses of defending itself against any claim or liability in connection with the exercise
or performance of any of its powers or duties hereunder. The Trustee shall notify the Company promptly of any claim asserted against the Trustee for which it may seek indemnity. 

The failure by the Trustee to so notify the Company shall not however relieve the Company of its obligations. Notwithstanding the foregoing,
the Company need not reimburse the Trustee for any expense or indemnify it against any loss or liability incurred by the Trustee through its negligence or bad faith. To secure the payment obligations of the Company in this Section 7.7, the
Trustee shall have a lien prior to the Securities of any Series on all money or property held or collected by the Trustee except such money or property held in trust to pay the principal of, interest and premium, if any, on particular
Securities of that Series. 
 When the Trustee incurs expenses or renders services after an Event of Default specified in
Section 6.1(4) or (5) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law. 

For purposes of this Section 7.7, the term “Trustee” shall include any trustee appointed pursuant to this Article 7. 

7.8. REPLACEMENT OF TRUSTEE. 
 The
Trustee may resign with respect to the Securities of one or more Series by so notifying the Company in writing at least 90 days in advance of such resignation. 

The Holders of a majority in principal amount of the outstanding Securities of any Series may remove the Trustee with respect to that
Series by notifying the removed Trustee in writing and may appoint a successor Trustee with respect to that Series with the consent of the Company, which consent shall not be unreasonably withheld. The Company may remove the Trustee with
respect to that Series at its election if: 
 (1) the Trustee fails to comply with, or ceases to be eligible under, Section 7.10;

 (2) the Trustee is adjudged a bankrupt or an insolvent, or an order for relief is entered with respect to the Trustee, under any
Bankruptcy Law; 
 (3) a Custodian or other public officer takes charge of the Trustee or its property; or 

(4) the Trustee otherwise becomes incapable of acting. 

(5) If the Trustee resigns or is removed, or if a vacancy exists in the office of Trustee, with respect to any Series of Securities for
any reason, the Company shall promptly appoint, by Board Resolution, a successor Trustee. 

  
 19 

 If a successor Trustee with respect to the Securities of one or more Series does not
take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of at least 10% in principal amount of the outstanding Securities of the applicable Series may petition any court
of competent jurisdiction for the appointment of a successor Trustee. 
 If the Trustee with respect to the Securities of one or more
Series fails to comply with Section 7.10, any Securityholder of the applicable Series may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately following
such delivery, (i) the retiring Trustee with respect to one or more Series shall, subject to its rights under Section 7.7, transfer all property held by it as Trustee with respect to such Series to the successor Trustee,
(ii) the resignation or removal of the retiring Trustee shall become effective and (iii) the successor Trustee with respect to such Series shall have all the rights, powers and duties of the Trustee under this Indenture. A successor
Trustee with respect to the Securities of one or more Series shall mail notice of its succession to each Securityholder of such Series. 

7.9. SUCCESSOR TRUSTEE BY CONSOLIDATION, MERGER OR CONVERSION. 

If the Trustee, or any Agent, consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust assets
to, another corporation, subject to Section 7.10, the successor corporation without any further act shall be the successor Trustee or Agent, as the case may be. 

7.10. ELIGIBILITY; DISQUALIFICATION. 

This Indenture shall always have a Trustee who satisfies the requirements of TIA Sections 310(a)(1), (2) and (5) in every respect.
The Trustee (or in the case of a Trustee that is a Person included in a bank holding company system, the related bank holding company) shall have a combined capital and surplus of at least $100,000,000 as set forth in its most recent published
annual report of condition. The Trustee shall comply with TIA Section 310(b), including the provision in Section 310(b)(1). In addition, if the Trustee is a Person included in a bank holding company system, the Trustee, independently of
such bank holding company, shall meet the capital requirements of TIA Section 310(a)(2). If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section 7.10, it shall resign immediately in the
manner and with the effect specified in this Article 7. 
 7.11. PREFERENTIAL COLLECTION OF CLAIMS AGAINST COMPANY. 

The Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who has
resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated therein. 
 7.12. PAYING AGENTS. 

The Company shall cause each Paying Agent other than the Trustee to execute and deliver to it and the Trustee an instrument in which such agent
shall agree with the Trustee, subject to the provisions of this Section 7.12: 
 (1) that it will hold all sums held by it as agent for
the payment of the principal of, or interest or premium, if any, on, the Securities (whether such sums have been paid to it by the Company or by any obligor on the Securities) in trust for the benefit of Holders of the Securities or the Trustee;

 (2) that it will at any time during the continuance of any Event of Default, upon written request from the Trustee, deliver to the
Trustee all sums so held in trust by it together with a full accounting thereof; and 
 (3) that it will give the Trustee written notice
within three Business Days after any failure of the Company (or by any obligor on the Securities) in the payment of any installment of the principal of, or interest or premium, if any, on, the Securities when the same shall be due and payable. 

  
 20 

 ARTICLE 8 – 

AMENDMENTS, SUPPLEMENTS AND WAIVERS 

8.1. WITHOUT CONSENT OF HOLDERS. 

The Company, when authorized by a Board Resolution, and the Trustee may amend, restate or supplement this Indenture or the Securities of one or
more Series without notice to or consent of any Securityholder: 
 (1) to comply with Section 5.1; 

(2) to provide for certificated Securities in addition to uncertificated Securities; 

(3) to comply with any requirements of the SEC under the TIA; 

(4) to cure any ambiguity, defect or inconsistency, or to make any other change herein or in the Securities that does not materially and
adversely affect the rights of any Securityholder; 
 (5) to provide for the issuance of, and establish the form and terms and conditions
of, Securities of any Series as permitted by this Indenture; or 
 (6) to evidence and provide for the acceptance of appointment
hereunder by a successor Trustee with respect to the Securities of one or more Series, and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by
more than one Trustee. 
 The Trustee is hereby authorized to join with the Company in the execution of any supplemental indenture
authorized or permitted by the terms of this Indenture, and to make any further appropriate agreements and stipulations which may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture which
adversely affects its own rights, duties or immunities under this Indenture. 
 8.2. WITH CONSENT OF HOLDERS. 

(a) The Company, when authorized by a Board Resolution, and the Trustee may amend, restate or supplement this Indenture or the Securities of
one or more Series with the written consent of the Holders of not less than a majority in aggregate principal amount of the outstanding Securities of such Series affected by such amendment, restatement or supplement without notice to any
Securityholder. The Holders of not less than a majority in aggregate principal amount of the outstanding Securities of each such Series affected by such amendment, restatement or supplement may waive compliance by the Company in a particular
instance with any provision of this Indenture or the Securities of such Series without notice to any Securityholder. Subject to Section 8.4, without the consent of each Securityholder affected, however, an amendment, supplement or waiver
may not: 
 (1) reduce the amount of Securities whose Holders must consent to an amendment, supplement or waiver to this Indenture or the
Securities; 
 (2) reduce the rate of, or change the time for payment of, interest on any Security; 

(3) reduce the principal, or change the Stated Maturity, of any Security, or reduce the amount of, or postpone the date fixed for, the payment
of any sinking fund or analogous obligation; 
 (4) make any Security payable in a currency other than that stated in the Security; 

(5) change the amount or time of any payment required by the Securities, or reduce the premium payable upon any redemption of the Securities,
or change the time before which no such redemption may be made; 
 (6) waive a Default or Event of Default in the payment of the principal
of, or interest or premium, if any, on, any Security (except a rescission of acceleration of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series and a waiver
of the payment default that resulted from such acceleration); 
 (7) waive a redemption payment with respect to any Security, or change any
of the provisions with respect to the redemption of any Securities; 
 (8) make any changes in Section 6.6 or this Section 8.2,
except to increase any percentage of Securities the Holders of which must consent to any matter; or 
 (9) take any other action otherwise
prohibited by this Indenture to be taken without the consent of each Holder affected thereby. 
 (b) Upon the request of the Company,
accompanied by a Board Resolution authorizing the execution of any such supplemental indenture, and upon the receipt by the Trustee of evidence reasonably satisfactory to the Trustee of the consent of the Securityholders as aforesaid and of the
documents described in Section 8.6, the Trustee shall join with the Company in the execution of such supplemental indenture, unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture, in
which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture. 

  
 21 

 (c) It shall not be necessary for the consent of the Holders under this section to approve
the particular form of any proposed amendment, restatement, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. 

After an amendment, restatement or supplement under this Section becomes effective, the Company shall mail to Securityholders a notice
briefly describing the amendment, restatement or supplement. Any failure of the Company to mail any such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any supplemental indenture. 

8.3. COMPLIANCE WITH TRUST INDENTURE ACT. 

Every amendment to, or supplement of, this Indenture or the Securities shall comply with the TIA as then in effect. 

8.4. REVOCATION AND EFFECT OF CONSENTS. 

Until an amendment, restatement, supplement, waiver or other action becomes effective, a consent to it by a Holder of a Security is a
continuing consent conclusive and binding upon such Holder and every subsequent Holder of the same Security or portion thereof, and of any Security issued upon the transfer thereof or in exchange therefor or in place thereof, even if notation of the
consent is not made on any such Security. Any such Holder or subsequent Holder, however, may revoke the consent as to his Security or portion of a Security, if the Trustee receives the notice of revocation before the date the amendment, restatement,
supplement, waiver or other action becomes effective. 
 The Company may, but shall not be obligated to, fix a record date for the purpose
of determining the Holders entitled to consent to any amendment, restatement, supplement or waiver, which record date shall be at least 30 days prior to the first solicitation of such consent. If a record date is fixed, then, notwithstanding
the preceding paragraph, those Persons who were Holders at such record date (or their duly designated proxies), and only such Persons, shall be entitled to consent to such amendment, restatement, supplement or waiver, or to revoke any consent
previously given, whether or not such Persons continue to be Holders after such record date. 
 After an amendment, restatement, supplement,
waiver or other action becomes effective, it shall bind every Securityholder, unless it makes a change described in any of clauses (1) through (9) of Section 8.2. In that case, the amendment, restatement, supplement, waiver or other
action shall bind each Holder of a Security who has consented to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security; PROVIDED, that any such waiver shall not
impair or affect the right of any Holder to receive payment of the principal of, and interest and premium, if any, on, a Security, on or after the respective due dates expressed in such Security, or to bring suit for the enforcement of any such
payment on or after such respective dates without the consent of such Holder. 
 8.5. NOTATION ON OR EXCHANGE OF SECURITIES. 

If an amendment, restatement, supplement or waiver changes the terms of a Security of any Series, the Trustee may request the Holder of such
Security to deliver it to the Trustee. In such case, the Trustee shall place an appropriate notation on such Security about the changed terms and return it to the Holder. Alternatively, the Company, in exchange for such Security, may issue, and the
Trustee shall authenticate, a new security that reflects the changed terms. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, restatement, supplement or waiver. 

8.6. TRUSTEE TO SIGN AMENDMENTS, ETC. 

The Trustee shall sign any amendment, restatement, supplement or waiver authorized pursuant to this Article 8 if the amendment,
restatement, supplement or waiver does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing or refusing to sign such amendment, restatement, supplement or
waiver the Trustee shall be entitled to receive and, subject to Section 7.1, shall be fully protected in relying upon an Officers’ Certificate and an Opinion of Counsel stating that such amendment, restatement, supplement or waiver is
authorized or permitted by this Indenture. The Company may not sign an amendment, restatement or supplement until the Board of Directors of the Company approves it. 

ARTICLE 9 – 

DISCHARGE OF INDENTURE; DEFEASANCE 

9.1. DISCHARGE OF INDENTURE. 
 The
Company may terminate its obligations under the Securities of any Series and this Indenture with respect to such Series, except the obligations referred to in the last paragraph of this Section 9.1, if there shall have been canceled by the
Trustee, or delivered 

  
 22 

 
to the Trustee for cancellation, all Securities of such Series theretofore authenticated and delivered (other than any Securities of such Series that are asserted to have been
destroyed, lost or stolen and that shall have been replaced as provided in Section 2.8) and the Company has paid all sums payable by it hereunder or deposited all required sums with the Trustee. 

After such delivery the Trustee upon request shall acknowledge in a writing prepared by or on behalf of the Company the discharge of the
Company’s obligations under the Securities of such Series and this Indenture, except for those surviving obligations specified below. 

Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company in Sections 7.7, 9.5 and 9.6 shall
survive. 
 9.2. LEGAL DEFEASANCE. 

The Company may at its option, by Board Resolution, be discharged from its obligations with respect to the Securities of any Series on the
date upon which the conditions set forth in Section 9.4 below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, such Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire
Indebtedness represented by the Securities of such Series and to have satisfied all its other obligations under such Securities and this Indenture insofar as such Securities are concerned (and the Trustee, at the expense of the Company, shall,
subject to Section 9.6, execute proper instruments acknowledging the same, as are delivered to it by the Company), except for the following, which shall survive until otherwise terminated or discharged hereunder: (A) the rights of Holders
of outstanding Securities of such Series to receive solely from the trust funds described in Section 9.4 and as more fully set forth in such section, payments in respect of the principal of, and interest and premium, if any, on, the
Securities of such Series when such payments are due, (B) the Company’s obligations with respect to the Securities of such Series under Sections 2.4, 2.5, 2.6, 2.7, 2.8 and 2.9, (C) the rights, powers, trusts, duties
and immunities of the Trustee hereunder (including claims of, or payments to, the Trustee under or pursuant to Section 7.7) and (D) this Article 9. Subject to compliance with this Article 9, the Company may exercise its option
under this Section 9.2 with respect to the Securities of any Series notwithstanding the prior exercise of its option under Section 9.3 below with respect to the Securities of such Series. 

9.3. COVENANT DEFEASANCE. 
 At the
option of the Company, pursuant to a Board Resolution, the Company shall be released from its obligations with respect to the outstanding Securities of any Series under Sections 4.2 through 4.5, inclusive, and Section 5.1, with
respect to the outstanding Securities of such Series, on and after the date the conditions set forth in Section 9.4 are satisfied (hereinafter, “Covenant Defeasance”). For this purpose, such Covenant Defeasance means that the Company
may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such specified section or portion thereof, whether directly or indirectly by reason of any reference elsewhere herein to any such
specified Section or portion thereof or by reason of any reference in any such specified section or portion thereof to any other provision herein or in any other document, but the remainder of this Indenture and the Securities of any
Series shall be unaffected thereby. 
 9.4. CONDITIONS TO LEGAL DEFEASANCE OR COVENANT DEFEASANCE. 

The following shall be the conditions to application of Section 9.2 or Section 9.3 to the outstanding Securities of a Series: 

(1) the Company shall irrevocably have deposited or caused to be deposited with the Trustee (or another trustee satisfying the requirements of
Section 7.10 who shall agree to comply with the provisions of this Article 9 applicable to it) as funds in trust for the purpose of making the following payments, specifically pledged as security for, and dedicated solely to, the benefit
of the Holders of the Securities, (A) money in an amount, or (B) U.S. Government Obligations or Foreign Government Obligations which through the scheduled payment of principal and interest in respect thereof in accordance with their terms
will provide, not later than the due date of any payment, money in an amount, or (C) a combination thereof, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification
thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or other qualifying trustee) to pay and discharge, the principal of, and accrued interest and premium, if any, on, the outstanding Securities of such
Series at the Stated Maturity of such principal, interest or premium, if any, or on dates for payment and redemption of such principal, interest and premium, if any, selected in accordance with the terms of this Indenture and of the Securities
of such Series; 
 (2) no Event of Default or Default with respect to the Securities of such Series shall have occurred and be
continuing on the date of such deposit, or shall have occurred and be continuing at any time during the period ending on the 91st day after the date of such deposit or, if longer, ending on the day following the expiration of the longest preference
period under any Bankruptcy Law applicable to the Company in respect of such deposit as specified in the Opinion of Counsel identified in paragraph (8) below (it being understood that this condition shall not be deemed satisfied until the
expiration of such period); 

  
 23 

 (3) such Legal Defeasance or Covenant Defeasance shall not cause the Trustee to have a
conflicting interest for purposes of the TIA with respect to any securities of the Company; 
 (4) such Legal Defeasance or Covenant
Defeasance shall not result in a breach or violation of, or constitute default under, any other agreement or instrument to which the Company is a party or by which it is bound; 

(5) the Company shall have delivered to the Trustee an Opinion of Counsel stating that, as a result of such Legal Defeasance or Covenant
Defeasance, neither the trust nor the Trustee will be required to register as an investment company under the Investment Company Act of 1940, as amended; 

(6) in the case of an election under Section 9.2, the Company shall have delivered to the Trustee an Opinion of Counsel stating that
(i) the Company has received from, or there has been published by, the Internal Revenue Service a ruling to the effect that or (ii) there has been a change in any applicable Federal income tax law with the effect that, and such opinion
shall confirm that, the Holders of the outstanding Securities of such Series or Persons in their positions will not recognize income, gain or loss for Federal income tax purposes solely as a result of such Legal Defeasance and will be subject
to Federal income tax on the same amounts, in the same manner, including as a result of prepayment, and at the same times as would have been the case if such Legal Defeasance had not occurred; 

(7) in the case of an election under Section 9.3, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect
that the Holders of the outstanding Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such Covenant Defeasance, and will be subject to Federal income tax on the same amounts, in the
same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 
 (8) the Company shall have
delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for in this Article 9 relating to either the Legal Defeasance under Section 9.2 or the Covenant
Defeasance under Section 9.3 (as the case may be) have been complied with; 
 (9) the Company shall have delivered to the Trustee an
Officers’ Certificate stating that the deposit under clause (1) was not made by the Company with the intent of defeating, hindering, delaying or defrauding any creditors of the Company or others; and 

(10) the Company shall have paid, or duly provided for payment under terms mutually satisfactory to the Company and the Trustee, all amounts
then due to the Trustee pursuant to Section 7.7. 
 9.5. DEPOSITED MONEY AND U.S. AND FOREIGN GOVERNMENT OBLIGATIONS TO BE HELD IN TRUST; OTHER
MISCELLANEOUS PROVISIONS. 
 All money, U.S. Government Obligations and Foreign Government Obligations (including the proceeds thereof)
deposited with the Trustee pursuant to Section 9.4 in respect of the outstanding Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Securities and this Indenture, to the payment, either
directly or through any Paying Agent as the Trustee may determine, to the Holders of such Securities, of all sums due and to become due thereon in respect of principal, accrued interest and premium, if any, but such money need not be segregated from
other funds except to the extent required by law. 
 The Company shall pay and indemnify the Trustee against any tax, fee or other charge
imposed on or assessed against the U.S. Government Obligations and Foreign Government Obligations deposited pursuant to Section 9.4 or the principal, interest and premium, if any, received in respect thereof other than any such tax, fee or
other charge which by law is for the account of the Holders of the outstanding Securities. 
 Anything in this Article 9 to the
contrary notwithstanding, but subject to payment of any of its outstanding fees and expenses, the Trustee shall deliver or pay to the Company from time to time upon Company Request any money, U.S. Government Obligations or Foreign Government
Obligations held by the Trustee as provided in Section 9.4 which, in the opinion of a nationally-recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, are in excess of the
amount thereof which would then be required to be deposited to effect an equivalent Legal Defeasance or Covenant Defeasance. 
 9.6. REINSTATEMENT.

 If the Trustee or Paying Agent is unable to apply any money, U.S. Government Obligations or Foreign Government Obligations in
accordance with Section 9.1, 9.2, 9.3 or 9.4 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s
obligations under this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article 9 until such time as the Trustee or Paying Agent is permitted to apply all such money, U.S.
Government Obligations or Foreign Government Obligations, as the case may be, in accordance with Section 9.1, 9.2, 9.3 or 9.4; PROVIDED, HOWEVER, that if the Company has 

  
 24 

 
made any payment of principal of, or accrued interest or premium, if any, on, any Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the
Holders of such Securities to receive such payment from the money, U.S. Government Obligations or Foreign Government Obligations held by the Trustee or Paying Agent. 

9.7. MONEYS HELD BY PAYING AGENT. 

In connection with the satisfaction and discharge of this Indenture, all moneys then held by any Paying Agent under the provisions of this
Indenture shall, upon demand of the Company, be paid to the Trustee, or, if sufficient moneys have been deposited pursuant to Section 9.1, be paid to the Company, and thereupon such Paying Agent shall be released from all further liability with
respect to such moneys. 
 9.8. MONEYS HELD BY TRUSTEE. 

Any moneys deposited with the Trustee or any Paying Agent or then held by the Company in trust for the payment of the principal of, or interest
or premium, if any, on, any Security that are not applied but remain unclaimed by the Holder of such Security for two years after the date upon which the principal of, or interest or premium, if any, on, such Security shall have respectively become
due and payable shall be repaid to the Company upon Company Request, or if such moneys are then held by the Company in trust, such moneys shall be released from such trust; and the Holder of such Security entitled to receive such payment shall
thereafter, as an unsecured general creditor, look only to the Company for the payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money shall thereupon cease. After payment to the Company or the release
of any money held in trust by the Company, Securityholders entitled to the money must look only to the Company for payment as general creditors, unless applicable abandoned property law designates another Person. 

ARTICLE 10 – 

MISCELLANEOUS 
 10.1. TRUST
INDENTURE ACT CONTROLS. 
 If any provision of this Indenture limits, qualifies or conflicts with another provision which is required to
be included in this Indenture by the TIA, the required TIA provision shall control. If any provision of this Indenture modifies or excludes any provision of the TIA which may be so modified or excluded, the latter provision shall be deemed to apply
to this Indenture as so modified or to be excluded, as the case may be. 
 10.2. NOTICES. 

Any notice or communication shall be given in writing and delivered in Person, sent by facsimile (and receipt confirmed by telephone or
electronic transmission report), delivered by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows: 
 If to the
Company: 
 Aeglea BioTherapeutics, Inc. 

805 Las Cimas Parkway, Suite 100 

Austin, TX 78746 
 Attention:
Chief Financial Officer 
 Copy to: 

Fenwick & West LLP 

555 California Street 
 San
Francisco, CA, 94104 
 Fax: (650) 988-5200 

Attention: Robert Freedman 
 If to the
Trustee: 
 The Company or the Trustee by written notice to the other may designate additional or different addresses for subsequent notices
or communications. Any notice or communication to the Company or the Trustee shall be deemed to have been given or made as of the date so delivered if personally delivered; when receipt is confirmed by telephone or electronic transmission report, if
sent by facsimile; and three Business Days after mailing if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed to have been given until actually received by the addressee). 

  
 25 

 Any notice or communication mailed to a Securityholder shall be mailed to such
Securityholder by first-class mail, postage prepaid, at such Securityholder’s address shown on the register kept by the Registrar. 

Failure to mail, or any defect in, a notice or communication to a Securityholder shall not affect its sufficiency with respect to other
Securityholders. If a notice or communication to a Securityholder is mailed in the manner provided above, it shall be deemed duly given, three Business Days after such mailing, whether or not the addressee receives it. 

In case by reason of the suspension of regular mail service, or by reason of any other cause, it shall be impossible to mail any notice as
required by this Indenture, then such method of notification as shall be made with the approval of the Trustee shall constitute a sufficient mailing of such notice. 

In the case of Global Securities, notices or communications to be given to Securityholders shall be given to the Depository, in accordance
with its applicable policies as in effect from time to time. 
 In addition to the manner provided for in the foregoing provisions, notices
or communications to Securityholders may be given by the Company by release made to Reuters Economic Services and Bloomberg Business News. 

10.3. COMMUNICATIONS BY HOLDERS WITH OTHER HOLDERS. 

Securityholders of any Series may communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or
any other Series with respect to their rights under this Indenture or the Securities of that Series or any other Series. The Company, the Trustee, the Registrar and any other Person shall have the protection of TIA Section 312(c).

 10.4. CERTIFICATE AND OPINION AS TO CONDITIONS PRECEDENT. 

Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the
Trustee: 
 (1) an Officers’ Certificate (which shall include the statements set forth in Section 10.5 below) stating that, in the
opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 

(2) an Opinion of Counsel (which shall include the statements set forth in Section 10.5 below) stating that, in the opinion of such
counsel, all such conditions precedent have been complied with. 
 10.5. STATEMENT REQUIRED IN CERTIFICATE AND OPINION. 

Each certificate and opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than pursuant to
Section 4.4) shall include: 
 (1) a statement that the Person making such certificate or opinion has read such covenant or condition;

 (2) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in
such certificate or opinion are based; 
 (3) a statement that, in the opinion of such Person, it or he has made such examination or
investigation as is necessary to enable it or him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4) a statement as to whether or not, in the opinion of such Person, such covenant or condition has been complied with. 

10.6. RULES BY TRUSTEE AND AGENTS. 

The Trustee may make reasonable rules for action by or at meetings of Securityholders. The Registrar, Paying Agent and Service Agent may
make reasonable rules for their functions. 

  
 26 

 10.7. BUSINESS DAYS; LEGAL HOLIDAYS; PLACE OF PAYMENT. 

A “Business Day” is a day that is not a Legal Holiday. A “Legal Holiday” is a Saturday, a Sunday, a federally-recognized
holiday or a day on which banking institutions are not authorized or required by law, regulation or executive order to be open in the State of New York. 

If a payment date is a Legal Holiday at a Place of Payment, payment may be made at that place on the next succeeding day that is not a Legal
Holiday, and no interest shall accrue for the intervening period. “Place of Payment” means the place or places where the principal of, and interest and premium, if any, on, the Securities of a Series are payable as specified as
contemplated by Section 2.2. If the regular record date is a Legal Holiday, the record date shall not be affected. 
 10.8. GOVERNING LAW.

 THIS INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS
APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. 
 10.9. NO ADVERSE
INTERPRETATION OF OTHER AGREEMENTS. 
 This Indenture may not be used to interpret another indenture, loan, security or debt agreement of
the Company or any Subsidiary thereof. No such indenture, loan, security or debt agreement may be used to interpret this Indenture. 
 10.10. NO
RECOURSE AGAINST OTHERS. 
 A director, officer, employee, stockholder or incorporator, as such, of the Company shall not have any
liability for any obligations of the Company under the Securities or the Indenture. Each Securityholder by accepting a Security waives and releases all such liability. Such waiver and release are part of the consideration for the issuance of the
Securities. 
 10.11. SUCCESSORS. 

All covenants and agreements of the Company in this Indenture and the Securities shall bind the Company’s successors and assigns, whether
so expressed or not. All agreements of the Trustee, any additional trustee and any Paying Agents in this Indenture shall bind their respective successors and assigns. 

10.12. MULTIPLE COUNTERPARTS. 
 The
parties may sign multiple counterparts (which may include counterparts delivered by any standard form of telecommunication) of this Indenture. Each signed counterpart shall be deemed an original, but all of them together represent one and the same
agreement. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronics Signatures and Records Act or other
applicable law, e.g., www.docusign.com) or other transmission method and any counterparty so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. 

10.13. TABLE OF CONTENTS, HEADINGS, ETC. 

The table of contents, cross-reference sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of
reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 

10.14. SEVERABILITY. 
 Each provision
of this Indenture shall be considered separable, and if for any reason any provision which is not essential to the effectuation of the basic purpose of this Indenture or the Securities shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby, and a Holder shall have no claim therefor against any party hereto. 

  
 27 

 10.15. SECURITIES IN A FOREIGN CURRENCY OR IN EUROS. 

Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to
Section 2.2 with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage in aggregate principal amount of Securities of all Series or all
Series affected by a particular action at the time outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars (including Euros), then the principal amount of
Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For purposes of this
Section 10.15, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for cable transfers of that currency as published by the Federal Reserve Bank of New York; PROVIDED, HOWEVER, in the case of Euros, Market
Exchange Rate shall mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal of the European Union (such publication or any successor publication, the
“Journal”). If such Market Exchange Rate is not available for any reason with respect to such currency, the Trustee shall use, in its sole discretion and without liability on its part, such quotation of the Federal Reserve Bank of New York
or, in the case of Euros, the rate of exchange as published in the Journal, as of the most recent available date, or quotations or, in the case of Euros, rates of exchange from one or more major banks in New York City or in the country of issue of
the currency in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of Euros, rates of exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this paragraph shall
apply in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection with any action taken by Holders of Securities pursuant to the terms of this Indenture. 

All decisions and determinations of the Trustee regarding the Market Exchange Rate or any alternative determination provided for in the
preceding paragraph shall be in the Trustee’s sole discretion, and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all purposes and irrevocably binding upon the Company and all Holders. 

10.16. JUDGMENT CURRENCY. 
 The
Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the principal of, or interest or
premium, if any, or other amount on, the Securities of any Series (the “Required Currency”) into a currency in which a judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at
which, in accordance with normal banking procedures, the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a Business
Day, in which instance, the rate of exchange used shall be the rate at which, in accordance with normal banking procedures, the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the Business Day
preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency (i) shall not be discharged or satisfied by any tender or any recovery pursuant to any
judgment (whether or not entered in accordance with subsection (a)) in any currency other than the Required Currency, except to the extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the
Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual
receipt shall fall short of the full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by judgment being obtained for any other sum due under this Indenture. 

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 

  
 28 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, and
their respective corporate seals to be hereunto affixed and attested, all as of the day and year first above written. 
  

					
	AEGLEA BIOTHERAPEUTICS, INC.
		
	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

	
	[Name of Trustee]
		
	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

		
	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

  
 29Exhibit 10.5

 

 

 

 

 

 

 

 

 

 

 

 

LIMITED LIABILITY
COMPANY MEMBERSHIP INTEREST

 

PURCHASE AGREEMENT

 

by and between

 

BRISTOL CAPITAL
INVESTORS, LLC

a Delaware limited liability
company

 

as Seller

 

and

 

CANNAPHARMARX INC.

a Delaware corporation

 

as Buyer

 

 

 

 

 

 

 

 

 

 

Dated as of June
24, 2020

 

  

    	 	 	 

     

    

 

Table of Contents

 

	ARTICLE
    I. DEFINITIONS AND USAGE	1	 
	Section
    1.01 Definitions	1	 
	Section
    1.02 Usage	5	 
	ARTICLE
    II. SALE AND TRANSFER OF RRPC INTEREST; CLOSING	6	 
	Section
    2.01 RRPC Interest	6	 
	Section 2.02 Purchase
    Price	6	 
	Section
    2.03 Closing	6	 
	Section
    2.04 Closing Obligations	7	 
	ARTICLE
    III. REPRESENTATIONS AND WARRANTIES OF SELLER	8	 
	Section
    3.01 Organization and Good Standing	8	 
	Section
    3.02 Enforceability and Authority; No Conflict	8	 
	Section
    3.03 Capitalization of Company	9	 
	Section
    3.04 Property	9	 
	Section
    3.05 Legal Proceedings	9	 
	Section 3.06	10	 
	Section
    3.07 Insurance	10	 
	Section
    3.08 Brokers or Finders	10	 
	ARTICLE
    IV. REPRESENTATIONS AND WARRANTIES OF BUYER	10	 
	Section
    4.01 Organization and Good Standing	10	 
	Section
    4.02 Enforceability and Authority; No Conflict	10	 
	Section
    4.03 Investment Intent	11	 
	Section
    4.04 Certain Proceedings	11	 
	Section
    4.05 Brokers or Finders	11	 
	Section
    4.06 Acknowledgments	11	 
	ARTICLE
    V. COVENANTS OF SELLER	12	 
	Section
    5.01 Access and Investigation	12	 
	Section
    5.02 Filings and Notifications; Cooperation	12	 
	Section
    5.03 Notice	12	 
	ARTICLE
    VI. COVENANTS OF BUYER	13	 
	Section
    6.01 Filings and Notifications; Cooperation	13	 
	Section
    6.02 Notice	13	 
	ARTICLE
    VII. CONDITIONS PRECEDENT TO BUYER’S OBLIGATION TO CLOSE	13	 
	Section
    7.01 Accuracy of Sellers’ Representations	13	 
	Section
    7.02 Seller’s Performance	14	 
	Section
    7.03 Bring Down Certificate	14	 
	Section
    7.04 Governmental Authorizations	14	 
	Section
    7.05 No Conflict	14	 

 

 

 

    	 	i	 

     

    

 

	ARTICLE
    VIII. CONDITIONS PRECEDENT TO SELLER’S OBLIGATIONS TO CLOSE	14	 
	Section
    8.01 Accuracy of Buyer’s Representations	14	 
	Section
    8.02 Buyer’s Performance	14	 
	Section
    8.03 Bring Down Certificate	15	 
	Section
    8.04 No Legal Prohibition	15	 
	ARTICLE
    IX. TERMINATION	15	 
	Section
    9.01 Termination Events	15	 
	Section
    9.02 Effect of Termination	15	 
	ARTICLE
    X. DISCLAIMERS, RELEASE AND INDEMNITY	16	 
	Section
    10.01 Disclaimers by Seller	16	 
	Section
    10.02 Sale “As Is, Where Is.”	16	 
	Section
    10.03 Seller Released from Liability	17	 
	Section
    10.04 Disclosure Requirement Compliance	18	 
	Section
    10.05 Survival	19	 
	ARTICLE
    XI. INDEMNIFICATION; PAYMENT; REIMBURSEMENT; REMEDIES	19	 
	Section
    11.01 Survival; Remedies	19	 
	Section
    11.02 Indemnification, Payment, and Reimbursement by Seller	20	 
	Section
    11.03 Indemnification, Payment, and Reimbursement by Buyer	20	 
	Section
    11.04 Time Limitations	21	 
	Section
    11.05 Certain Limitations on Amount	21	 
	Section
    11.06 Third-Party Claims	21	 
	Section
    11.07 Other Claims	23	 
	Section
    11.08 Strict Liability or Indemnitee Negligence	23	 
	ARTICLE
    XII. MISCELLANEOUS	23	 
	Section
    12.01 Expenses	24	 
	Section
    12.02 Public Announcements	24	 
	Section
    12.03 Further Assurances	24	 
	Section
    12.04 Entire Agreement	24	 
	Section
    12.05 Modification	24	 
	Section
    12.06 Assignments and Successors	24	 
	Section
    12.07 No Third-Party Rights	24	 
	Section
    12.08 Remedies Cumulative	25	 
	Section
    12.09 Governing Law	25	 
	Section
    12.10 Jurisdiction; Service of Process	25	 
	Section
    12.11 Waiver of Jury Trial	25	 
	Section
    12.12 Attorneys’ Fees	25	 
	Section
    12.13 Enforcement of Agreement	25	 
	Section
    12.14 No Waiver	26	 
	Section
    12.15 Notices	26	 
	Section
    12.16 Severability	27	 
	Section
    12.17 Time of Essence	27	 
	Section
    12.18 Counterparts and Electronic Signatures	27	 

 

 

 

    	 	ii	 

     

    

 

LIMITED LIABILITY
COMPANY MEMBERSHIP INTEREST PURCHASE AGREEMENT

 

This
LIMITED LIABILITY COMPANY MEMBERSHIP INTEREST PURCHASE AGREEMENT (“Agreement”) is made as of June 24,
2020 by BRISTOL CAPITAL INVESTORS, LLC, a Delaware limited liability company (“Seller”), and CANNAPHARMARX
INC., a Delaware corporation (“Buyer”).

 

RECITALS

 

Seller
desires to sell, and Buyer desires to purchase, 100% of the issued and outstanding limited liability company membership interest
(the “RRPC Interest”) of RAMON ROAD PRODUCTION
CAMPUS, LLC, a Delaware corporation (the “Company”), for the consideration
and on the terms set forth in this Agreement.

 

The parties, intending to be legally
bound, agree as follows:

 

ARTICLE I.

DEFINITIONS
AND USAGE

 

Section
1.01 Definitions. For purposes of this Agreement, the following terms have the meanings specified or referred to in this
Section 1.01:

 

“Accident Lawsuits”—as
defined in Section 3.05(a).

 

“Agreement”—as defined in the first paragraph of this Agreement.

 

“Breach”—any
breach of, or any inaccuracy in, any representation or warranty or breach of, or failure to perform or comply with, any covenant
or obligation in or of the Contract in question, or any event that with the passing of time or the giving of notice, or both, would
constitute such a breach, inaccuracy, or failure.

 

“Business Day”—any
day other than (a) Saturday or Sunday or (b) any other day on which national banks in Los Angeles, California are generally permitted
or required to be closed.

 

“Buyer”—as defined
in the first paragraph of this Agreement.

 

“Buyer Group”—as defined in Section 5.01.

 

“Buyer Indemnified Persons”—as
defined in Section 11.02.

 

“Closing”—as defined in Section 2.03.

 

“Closing Date”—the
date on which the Closing occurs.

 

“Closing Payment”—as defined in Section 2.02.

 

“Company”—as
defined in the Recitals of this Agreement.

 

 

 

    	 	1	 

     

    

 

“Consent”—any
approval, consent, ratification, waiver, or other authorization.

 

“Contemplated Transactions”—the transactions
contemplated by this Agreement.

 

“Contract”—any
agreement, contract, lease, consensual obligation, promise, commitment, or undertaking (whether written or oral and whether express
or implied), whether or not legally binding.

 

“CPL”—as defined in Section
3.05(a).

 

“CPL Action”—as defined in
Section 3.05(a).

 

“Encumbrance”—any
charge, claim, community or other marital property interest, condition, equitable interest, lien, option, pledge, security interest,
mortgage, right of way, easement, encroachment, servitude, right of first option, right of first refusal, or similar restriction,
including any restriction on use, voting, transfer, receipt of income, or exercise of any other attribute of ownership.

 

“End Date”—as defined in Section
9.01(d).

 

“Exchange Act”—the
Securities Exchange Act of 1934.

 

“Escrow Agent”—as defined in the Escrow Agreement.

 

“Escrow Agreement”—as
defined in Section Section 2.04(a)(v).

 

“Escrow Funds”—as defined in Section 2.02.

 

“Existing Loan”—That
certain loan from Bobs LLC, a Nevada limited liability company, to Seller.

 

“Governmental
Authorization”—any (a) Consent, license, registration, or permit issued, granted, given, or otherwise made available
by or under the authority of any Governmental Body or pursuant to any Legal Requirement; or (b) right under any Contract with any
Governmental Body.

 

“Governmental
Body”—any nation, state, county, city, town, borough, village, district, or other jurisdiction; federal, state,
local, municipal, foreign, multinational, or other government; governmental or quasi-governmental authority of any nature (including
any agency, branch, department, board, commission, court, tribunal, or other entity exercising governmental or quasi- governmental
powers); body exercising, or entitled or purporting to exercise, any administrative, executive, judicial, legislative, police,
regulatory, or taxing authority or power, whether local, national, or international; or official of any of the foregoing.

 

“Hazardous
Material”—any substance, material, or waste that is or will foreseeably be regulated by any Governmental Body,
including any material, substance, or waste that is defined or classified as a “hazardous waste,” “hazardous
material,” “hazardous substance,” “extremely hazardous waste,” “pollutant,” “restricted
hazardous waste,” “contaminant,” “toxic waste,” “pollutant,” or “toxic substance”
under any provision of Environmental Law, including petroleum, petroleum products, asbestos, presumed asbestos-containing material
or asbestos-containing material, urea formaldehyde, or polychlorinated biphenyls.

 

 

 

    	 	2	 

     

    

 

 

“Improvements”—the improvements
located on the Real Property.

 

“Indemnified Person”—as defined in Section 11.06(a).

 

“Indemnifying
Person”—as defined in Section 11.06(a).

 

“Knowledge”—

 

(a)            An individual will be deemed to have Knowledge of a particular fact or other matter if: that individual is actually aware
of that fact or matter; or a prudent individual could be expected to discover or otherwise become aware of that fact or matter
in the course of conducting a reasonably comprehensive investigation regarding the accuracy of any representation or warranty in
this Agreement.

 

(b)          
A Person (other than an individual) will be deemed to have Knowledge of a particular fact or other matter if any individual
who is serving, or who has at any time served, as a director, officer, partner, manager, executor, or trustee of that Person (or
in any similar capacity) has, or at any time had, Knowledge of that fact or other matter (as set forth in clauses (a)(i) and (ii)
above).

 

“Legal
Requirement”—any constitution, law, ordinance, principle of common law, code, rule, regulation, statute, act, treaty,
or order of general applicability of any Governmental Body, including rules and regulations promulgated thereunder.

 

“RRPC Interest”—as defined
in the Recitals of this Agreement.

 

“Loss”—any
cost, loss, liability, obligation, claim, cause of action, damage, deficiency, expense (including costs of investigation and defense
and reasonable attorneys’ fees and expenses), fine, penalty, judgment, award, assessment, or diminution of value.

 

“Mechanics Liens Actions”—as
defined in Section 3.05(a).

 

“Natural Hazard Expert”—as defined in Section 10.04.

 

“Natural Hazard
Matters”—as defined in Section 10.04.

 

“Order”—any
order, injunction, judgment, decree, ruling, assessment, or arbitration award of any Governmental Body or arbitrator.

 

“Ordinary
Course of Business”—an action taken by a Person will be deemed to have been taken in the Ordinary Course of Business
only if that action: is consistent in nature, scope, and magnitude with the past practices of such Person and is taken in the
ordinary course of the normal, day-to-day operations of such Person; and does not require authorization by the board of directors
of such Person (or by any Person or group of Persons exercising similar authority) and does not require any other separate or
special authorization of any nature.

 

 

 

    	 	3	 

     

    

 

“Organizational
Documents”—(a) the articles or certificate of incorporation and the bylaws of a corporation; (b) the certificate
of formation and limited liability company agreement, operating agreement, or like agreement of a limited liability company; (c)
the partnership agreement and any statement of partnership of a general partnership; (d) the limited partnership agreement and
the certificate of limited partnership of a limited partnership; (e) any charter or agreement or similar document adopted or filed
in connection with the creation, formation, or organization of a Person; and (f) any amendment to or restatement of any of the
foregoing.

 

“Person”—an
individual, partnership, corporation, business trust, limited liability company, limited liability partnership, joint stock company,
trust, unincorporated association, joint venture, other entity, or a Governmental Body.

 

“Proceeding”—any
action, arbitration, mediation, audit, hearing, investigation, litigation, or suit (whether civil, criminal, administrative, judicial,
or investigative) commenced, brought, conducted, or heard by or before, or otherwise involving, any Governmental Body or arbitrator.

 

“Property”
means the Real Property and any other tangible or intangible property owned by the Company.

 

“Property Documents”—as
defined in Section 3.04.

 

“Purchase Price”—as defined in Section 2.02.

 

“Real Property”—as
defined in Section 3.04.

 

“Record”—information
that is inscribed on a tangible medium or that is stored in an electronic or other medium.

 

“Related Person”—

 

(a)           
With respect to an individual: each other member of such individual’s Family; any Person that is directly or indirectly
controlled by such individual or any one or more members of such individual’s Family; any Person in which members of such
individual’s Family hold (individually or in the aggregate) a Material Interest; and any Person with respect to which one
or more members of such individual’s Family serves as a director, officer, partner, manager, executor, or trustee (or in
a similar capacity).

 

(b)          
With respect to a Person other than an individual: any Person that directly or indirectly controls, is directly or indirectly
controlled by, or is directly or indirectly under common control with, such specified Person; any Person that holds a Material
Interest in such specified Person; each Person that serves as a director, officer, partner, manager, executor, or trustee of such
specified Person (or in a similar capacity); any Person in which such specified Person holds a Material Interest; and any Person
with respect to which such specified Person serves as a general partner, manager, or a trustee (or in a similar capacity).

 

 

 

    	 	4	 

     

    

 

(c)            For purposes of this definition:

 

(i)            
“control” (including “controlling,” “controlled by,” and “under common
control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management
and policies of a Person, whether through the ownership of voting securities, by contract, or otherwise, and shall be construed
as such term is used in the rules promulgated under the Exchange Act;

 

(ii)           
the “Family” of an individual includes (A) the individual, (B) the individual’s spouse, (C) any
other natural person who is related to the individual or the individual’s spouse within the second degree, and (D) any other
natural person who resides with such individual; and

 

(iii)          
“Material Interest” means direct or indirect beneficial ownership (as defined in Rule 13d-3 under the
Exchange Act) of voting securities or other voting interests representing at least 10% of the outstanding voting power of a Person
or Equity Securities representing at least 10% of the outstanding equity interests in a Person.

 

“Representative”—with
respect to a particular Person, includes any director, officer, manager, employee, agent, consultant, advisor, accountant, financial
advisor, or legal counsel of such Person.

 

“RRPC
Operating Agreement”—the Operating Agreement of the Company dated October 17, 2017, as amended.

 

“Securities Act”—the Securities
Act of 1933.

 

“Seller”—as defined
in the first paragraph of this Agreement.

 

“Seller’s Environmental Reports”—as defined in Section
10.04.

 

“Seller Indemnified Persons”—as defined in Section 11.03 “Spacebugs”—as
defined in Section 3.05(a).

 

“Spacebugs Action”—as defined
in Section 3.05(a).

 

“Third Party”—a Person that
is not an The Company or a party to this Agreement.

 

“Third-Party
Claim”—any claim against any Indemnified Person by a Third Party, whether or not involving a Proceeding.

 

Section
1.02 Usage

 

(a)           
In this Agreement, unless expressly stated otherwise: the singular includes the plural and vice versa; reference to any
Person includes such Person’s successors and assigns, if applicable, but only if such successors and assigns are permitted
by this Agreement, and reference to a Person in a particular capacity excludes such Person in any other capacity; reference to
a gender includes the other gender; reference to any agreement, document, or instrument means such agreement, document, or instrument
as amended or modified and in effect from time to time in accordance with its terms; reference to any Legal Requirement means
that Legal Requirement as from time to time in effect, including any amendment, modification, codification, replacement, or reenactment
of such Legal Requirement; reference to any section or other provision of any Legal Requirement means that provision of such Legal
Requirement as from time to time in effect, including any amendment, modification, codification, replacement, or reenactment of
such section or other provision; “hereunder,” “hereof,” “hereto,” and words of similar import
refer to this Agreement as a whole and not to any particular Article, Section, or other provision of this Agreement; “including”
(and with correlative meaning “include”) means including without limiting the generality of any description preceding
such term; “or” is used in the inclusive sense of “and/or”; “any” means “any and all”;
with respect to the determination of any period of time, “from” means “from and including” and “to”
means “to but excluding”; a reference to a document, instrument, or agreement also refers to all addenda, exhibits,
or schedules thereto; a reference to a “copy” or “copies” of any document, instrument, or agreement means
a copy or copies that are complete and correct; and a reference to a list, or any like compilation, means that the item referred
to is complete and correct.

 

 

 

    	 	5	 

     

    

 

 

 

(b)           
This Agreement was negotiated by the parties with the benefit of legal representation, and any rule of construction or interpretation
otherwise requiring this Agreement to be construed or interpreted against any party as having been drafted by it will not apply
to any construction or interpretation of this Agreement.

 

(c)           
The headings contained in this Agreement are for convenience of reference only, shall not be deemed to be part of this Agreement,
and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

ARTICLE II.

SALE AND TRANSFER
OF RRPC INTEREST; CLOSING

 

Section
2.01 RRPC Interest. Subject to the terms and conditions of this Agreement, and in reliance upon the representations, warranties,
and covenants contained in this Agreement, at the Closing, Buyer shall purchase the RRPC Interest from Seller, and Seller shall
sell and transfer the RRPC Interest to Buyer, free and clear of any Encumbrance.

 

Section
2.02 Purchase Price. The purchase price for the RRPC Interest (the “Purchase Price”) is $10,000,000.
At the Closing, Buyer deliver as payment on account of the Purchase Price: (a) $9,000,000 (the “Closing Payment”),
which shall be paid by wire transfer to Seller pursuant to written wire transfer instructions delivered to Buyer by Seller at least
three Business Days prior to the Closing; and (b) $1,000,000 paid by wire transfer to the Escrow Agent pursuant to the Escrow Agreement
(the “Escrow Funds”).

 

Section
2.03 Closing. Subject to ARTICLE IX, the purchase and sale (the “Closing”) provided for in this Agreement
will take place at the offices of Shumaker Mallory LLP at 468 N. Camden Dr., Suite 350, Beverly Hills, California 90210 commencing
at 10:00 a.m. (local time) on July 22, 2020 or at such other date and time as Buyer and Seller may otherwise agree, provided that
on or prior to that date all conditions set forth in ARTICLE VII and ARTICLE VIII have been satisfied or waived. The parties need
not be present at the Closing, and the exchange of executed documents may be made by email or facsimile transmission. If all conditions
set forth in ARTICLE VII and ARTICLE VIII are not satisfied or waived by July 22, 2020, subject to ARTICLE IX, the Closing will
take place upon the earlier of (a) five (5) Business Days following notice given by Buyer stating that all conditions set forth
in ARTICLE VII and ARTICLE VIII have been satisfied or waived (other than conditions to be satisfied on the Closing Date), and
(b) the End Date. The Closing will be deemed to be effective as of the close of business on the Closing Date for tax and accounting
purposes.

 

 

 

 

 

 

 

    	 	6	 

     

    

 

Section
2.04 Closing Obligations. At the Closing:

 

 (a)            Seller’s Deliveries. Seller shall deliver to Buyer:

 

(i)            
Such instruments or documents necessary for the transfer of the RRPC Interest to Buyer pursuant to the terms of the RRPC
Operating Agreement;

 

(ii)           
the Organizational Documents of the Company filed with any Governmental Body in connection with its organization, duly certified
as of a recent date by the Secretary of State or other appropriate authority of the jurisdiction of its incorporation or organization,
together with a certificate dated as of the Closing Date from a Representative of the Company to the effect that no amendments
to such Organizational Documents have been filed since the date referred to above;

 

(iii)          
the Organizational Documents of the Company not filed with a Governmental Body in connection with its organization, certified
as of the Closing Date by a Representative of the Company;

 

(iv)         
certificates dated as of a date not more than five (5) days prior to the Closing Date as to the good standing of the Company,
issued by the appropriate Governmental Body of the jurisdiction of the Company’s organization and each jurisdiction in which
the Company is licensed or qualified to do business as a foreign entity;

 

(v)           
an escrow agreement in the form of Exhibit 2.04(a)(v), executed by Sellers (the “Escrow Agreement”);
and

 

(vi)           the certificate referred to in Section 7.03.

 

(b)              
Buyer’s Deliveries. Buyer shall deliver to Seller (or in the case of the Escrow Funds, to the Escrow Agent):

 

 (i)             the Purchase Price; and

 

(ii)           
the Escrow Funds;

 

(iii)          
the Escrow Agreement, executed by Buyer and the Escrow Agent;

 

and

 

(iv)           the certificate referred to in Section 8.03.

 

 

 

    	 	7	 

     

    

 

ARTICLE III.

REPRESENTATIONS
AND WARRANTIES OF SELLER

 

Seller represents and warrants to Buyer as follows:

 

Section
3.01 Organization and Good Standing.

 

(a)           
The Company is duly organized, validly existing, and in good standing under the laws of the State of Delaware, with full
power and authority to conduct its business as it is being conducted, to own or use its assets, and to perform all its obligations.
The Company is duly qualified to do business as a foreign entity and is in good standing under the laws of each jurisdiction that
requires such qualification.

 

(b)           
Seller is duly organized, validly existing, and in good standing under the laws of the State of Delaware, with full power
and authority to conduct its business as it is being conducted, to own or use its assets, and to perform all its obligations.

 

(c)           
Seller has delivered to Buyer copies of the Organizational Documents of the Company and of Seller. Neither Seller nor the
Company is in default under or in violation of any of its Organizational Documents.

 

Section
3.02 Enforceability and Authority; No Conflict.

 

(a)           
This Agreement and the Escrow Agreement have been duly executed and delivered by Seller and each constitutes the legal,
valid, and binding obligation of Seller, enforceable against Seller in accordance with its terms. Seller has the absolute and unrestricted
right, power, authority, and capacity to execute and deliver, and to perform its obligations under this Agreement and the Escrow
Agreement.

 

(b)            Neither
the execution and delivery of this Agreement nor the consummation or performance of any Contemplated Transaction will, directly
or indirectly (with or without notice or lapse of time):

 

(i)            
contravene, conflict with, or violate (A) any Organizational Document of the Company, or (B) any resolution adopted by Seller
as the sole member (or Persons exercising similar authority) of the Company;

 

(ii)           
contravene, conflict with, or violate, or give any Governmental Body or other Person the right to challenge any Contemplated
Transaction, or to exercise any remedy or obtain any relief under, any Legal Requirement or any Order to which the Company or Seller,
or any assets owned or used by the Company, could be subject;

 

(iii)          
contravene, conflict with, violate, result in the loss of any benefit to which the Company is entitled under, or give any
Governmental Body the right to revoke, suspend, cancel, terminate, or modify, any Governmental Authorization held by the Company
or that otherwise relates to the business of, or any assets owned or used by, the Company;

 

 

 

    	 	8	 

     

    

 

(c)          
Neither Seller nor the Company is required to give notice to, or obtain Consent from, any Person in connection with the
execution and delivery of this Agreement or the consummation or performance of any Contemplated Transaction.

 

Section
3.03 Capitalization of Company. Seller is the owner (of record and beneficially) of the RRPC Interest, free and clear of
all Encumbrances, including any restriction on the right of Seller to transfer the RRPC Interest to Buyer pursuant to this Agreement.
The RRPC Interest constitutes 100% of the outstanding membership interest of the Company. The instruments of transfer to be delivered
by Seller to Buyer at the Closing will be sufficient to transfer Seller’s entire interest in the RRPC Interest (of record
and beneficially) owned by Seller. At Closing, Buyer will receive good title to the RRPC Interest, free and clear of all Encumbrances.

 

Section
3.04 Property.

 

(a)          
Schedule 3.04(a) lists all real estate owned by the Company (the “Real Property”), including the
legal description, street address, and any tax parcel identification number of each property.

 

(b)          
Seller has delivered to Buyer copies of the deeds and other instruments by which the Company acquired the Real Property
and copies of the title insurance policies, opinions, abstracts, documents and surveys relating to the Real Property listed on
Schedule 3.04(b) (the “Property Documents”).

 

Section
3.05 Legal Proceedings.

 

 (a)            Certain Litigation.

 

(i)           
Buyer acknowledges that the Company is currently involved in litigation with CP Logistics, LLC (“CPL”)
as follows: (i) an arbitration pending before JAMS, CP Logistics, LLC v. Sunniva Production Campus, LLC, JAMS Reference
No. 1220064266; and (ii) Sunniva Production Campus, LLC v. CP Logistics, LLC, Los Angeles Superior Court Case No. 19STCV44348
(collectively “CPL Actions”).

 

(ii)           
Buyer acknowledges that the Company has been named as a defendant in Brittany Smith v. Prestige International Security,
Inc, et al., Riverside Superior Court Case No. PSC2000503. Seller’s defense of this matter has been tendered to insurance,
and tender has been accepted. the Company has also been named as a defendant in RLI Insurance Company v. City of Cathedral City,
et al., Riverside Superior Court, Palm Springs Court, Case No. PSC2000961. These two lawsuits are referred to collectively
as the “Accident Lawsuits.”

 

(iii)          
Buyer acknowledges that several mechanic’s lienholders have filed lawsuits to enforce such mechanic’s liens.
Buyer also acknowledges that Seller is involved in an arbitration proceeding with a vendor who might not have recorded a mechanic’s
lien, Logiqs BV v. Sunniva Production Campus, LLC, AAA Case No.: 01-20-000-4770. Pursuant to Section Section 4.06, Buyer
is assuming or paying off all such claims and debts related to mechanic’s liens (the “Mechanics Lien Actions”).

 

 

 

    	 	9	 

     

    

 

(iv)         
Buyer acknowledges that Spacebugs 2017, Inc., a Utah corporation (“Spacebugs”), has filed an action naming
Seller as a defendant in Spacebugs2017, Inc., et al., v. Bristol Capital Investors, LLC, et al., Los Angeles Superior Court
Case No. 20STCV20269 (the “Spacebugs Action”), for injunctive and declaratory relief to set aside Seller’s
acquisition of the RRPC Interest through a foreclosure and public sale under California Commercial Code §9610. On May 29,
2020, the Court denied Spacebug’s request for a temporary restraining order.

 

(b)          
To Seller's knowledge, except as otherwise disclosed by or contained in the Property Documents and the CPL Actions, the
Mechanics Liens Actions, the Accident Lawsuits and the Spacebugs Action, as of the Effective Date: (i) neither Seller nor the Company
is a party to any litigation or other court proceeding which materially adversely affects the Real Property or the Contemplated
Transactions; and (ii) Seller has not received any written notice threatening any such litigation or other court proceeding which
materially adversely affects the Real Property or the Contemplated Transactions.

 

Section
3.07 Insurance. Seller has delivered to Buyer:

 

(a)           
copies of all policies of insurance (and correspondence relating to coverage thereunder) to which the Company is a party,
an insured, or a beneficiary, or under which the Company, or any director, officer, or manager of the Company in his or her capacity
as such, is or has been covered at any time since January 1, 2020, a list of which is set forth on Schedule 3.07(a);

 

 (b)            copies of all pending applications for policies of insurance; and

 

(c)           
any written statement by the auditor of the Company or any consultant or risk management advisor provided to or in the possession
of the Company with regard to the adequacy of its coverage or its reserves for actual or potential claims.

 

Section
3.08 Brokers or Finders. Seller has not incurred any obligation or liability, contingent or otherwise, for any brokerage
or finder’s fee or agent’s commission or other similar payment in connection with this Agreement or the Contemplated
Transactions.

 

ARTICLE IV.

REPRESENTATIONS
AND WARRANTIES OF BUYER

 

Buyer represents and warrants to Seller as follows:

 

Section
4.01 Organization and Good Standing. Buyer is a corporation duly organized, validly existing, and in good standing under
the laws of the State of Delaware.

 

Section
4.02 Enforceability and Authority; No Conflict.

 

 

 

    	 	10	 

     

    

 

(a)           
The execution, delivery, and performance by Buyer of this Agreement and the Escrow Agreement have been duly authorized by
all necessary corporate action. This Agreement and the Escrow Agreement have been duly executed and delivered by Buyer and each
constitutes the legal, valid, and binding obligation of Buyer, enforceable against Buyer in accordance with its terms. Buyer has
the absolute and unrestricted right, power, and authority to

execute and deliver this Agreement and the Escrow
Agreement and to perform its obligations under this Agreement and the Escrow Agreement.

 

(b)           
Neither the execution and delivery of this Agreement nor the consummation or performance of any Contemplated Transaction
will directly or indirectly (with or without notice or lapse of time):

 

(i)            
contravene, conflict with, or violate (A) any Organizational Document of Buyer, or (B) any resolution adopted by the board
of directors or the shareholders of Buyer; or

 

(ii)           
contravene, conflict with, or violate, or give any Governmental Body or other Person the right to challenge any Contemplated
Transaction, or to exercise any remedy or obtain any relief under, any Legal Requirement or any Order to which Buyer, or any assets
owned or used by Buyer, is subject; or

 

(c)          
Buyer is not required to give notice to or obtain Consent from any Person in connection with the execution and delivery
of this Agreement or the consummation or performance of any Contemplated Transaction.

 

Section
4.03 Investment Intent. Buyer is acquiring the RRPC Interest for its own account and not with a view to its distribution
within the meaning of Section 2(11) of the Securities Act.

 

Section
4.04 Certain Proceedings. There is no Proceeding pending against Buyer that challenges, or could have the effect of preventing,
delaying, making illegal, imposing limitations or conditions on, or otherwise interfering with, any Contemplated Transaction. To
Buyer’s Knowledge, no such Proceeding has been threatened.

 

Section
4.05 Brokers or Finders. Neither Buyer nor any of its Representatives has incurred any obligation or liability, contingent
or otherwise, for any brokerage or finder’s fee, agent’s commission, or other similar payment in connection with this
Agreement or the Contemplated Transactions.

 

Section
4.06 Acknowledgments. Buyer acknowledges the following: (i) the Improvements have not been completed and there are several
existing mechanics’ liens recorded against the Property and other aged payables which Buyer must assume or pay off following
Closing, (ii) the Existing Loan on the Property has matured and is in default, and there is no assurance that such Existing Loan
will be extended or a foreclosure of the Property may not occur, and that Buyer will have the sole responsibility after the Closing
Date for refinancing or paying off the Existing Loan; (iii) CPL is asserting in the CPL Action that it has an enforceable lease
with the Company with respect to the Property and that the Company is liable for substantial damages, and that Buyer’s intended
use of the Property will be adversely affected if CPL should prevail in the CPL action or if the CPL Action is not resolved, (iv)
Buyer will be required to expend substantial funds to complete the Improvements on the Property and to pay off or settle all mechanic’s
liens to enable Buyer to obtain a certificate of occupancy; and (v) if the Spacebugs Action is not resolved by Buyer and Spacebugs
should prevail in the Spacebugs Action subsequent to the Closing Date, Buyer’s ownership of the RRPC Interest will be adversely
affected.

 

 

 

    	 	11	 

     

    

 

ARTICLE V.

COVENANTS
OF SELLER

 

Section
5.01 Access and Investigation.

 

(a)           
Prior to the Closing Date, and upon reasonable notice from Buyer, Seller shall, and shall cause the Company to, (a) afford
Buyer and its Representatives and prospective lenders and their Representatives (collectively, “Buyer Group”)
full and free access, during regular business hours, to the Company’s personnel, assets, Contracts, and Records, (b) furnish
Buyer Group with copies of all such Contracts and Records as Buyer may reasonably request, (c) furnish Buyer Group with such additional
financial, operating, and other relevant data and information as Buyer may reasonably request, and (d) otherwise cooperate and
assist, to the extent reasonably requested by Buyer, with Buyer’s investigation of the business, condition (financial or
otherwise), assets, results of operations, or prospects of the Company. In addition, Buyer shall have the right to have the Real
Property and the tangible personal property of the Company inspected by Buyer Group, at Buyer’s sole cost and expense, including
the performance of subsurface or other intrusive testing.

 

(b)          
Buyer hereby indemnifies, defends and holds Seller harmless from and against any and all liens, claims, causes of action,
damages, liabilities and expenses (including reasonable attorneys' fees) arising out of Buyer's inspections, investigations and/or
tests of the Property or any violation of the provisions of Section 5.01(a); provided, however, this indemnity shall not extend
to protect Seller from any pre-existing liabilities for matters merely discovered by Buyer (e.g., latent environmental contamination)
so long as Buyer's actions do not aggravate any pre-existing liability of Seller. Buyer's obligations under this Section 5.01 shall
survive the termination of this Agreement and shall survive the Closing.

 

Section
5.02 Filings and Notifications; Cooperation. As promptly as practicable after the date of this Agreement, and in any event
within the applicable time period prescribed by Legal Requirements, Seller shall, and shall cause the Company and each of their
Related Persons to, make all filings and notifications required by Legal Requirements to be made by them in connection with the
Contemplated Transactions. Seller shall, and shall cause the Company and each of their Related Persons to, cooperate with Buyer,
its Related Persons, and their respective Representatives (a) with respect to all filings and notifications that Buyer or its Related
Persons elect to make or shall be required by Legal Requirements to make in connection with the Contemplated Transactions, (b)
in identifying and obtaining the Governmental Authorizations required by Buyer to own and operate the Company from and after the
Closing Date, and (c) in obtaining all Consents identified in Schedule 5.02.

 

Section
5.03 Notice.

 

(a)           
Prior to the Closing Date, Seller shall promptly provide notice to Buyer of any Breach of any representation or warranty
of Seller or any fact or circumstance that would or would reasonably be likely to cause or constitute a Breach of any such representation
or warranty had that representation or warranty been made as of the time of the occurrence of such fact or circumstance. No such
notice or delivery will be deemed to have cured any Breach of any representation or warranty or affect any right or remedy of Buyer
under this Agreement.

 

 

 

    	 	12	 

     

    

 

(b)           
Prior to the Closing Date, Seller shall promptly provide notice to Buyer of any Breach of any covenant of Seller in this
ARTICLE V or any fact or circumstance that could make the satisfaction of any condition in ARTICLE VII impossible or unlikely and
of all corrective actions undertaken, or to be undertaken, by such Seller with respect thereto. No such notice will be deemed to
have cured any Breach of any covenant or affect any right or remedy of Buyer under this Agreement.

 

ARTICLE
VI.

COVENANTS OF BUYER

 

Section
6.01 Filings and Notifications; Cooperation. As promptly as practicable after the date of this Agreement, and in any event
within the applicable time period prescribed by Legal Requirements, Buyer shall, and shall cause each of its Related Persons to,
make all filings and notifications required by Legal Requirements to be made by them in connection with the Contemplated Transactions.
Buyer shall, and shall cause each of its Related Persons to, cooperate with Seller, the Company, their Related Persons and their
respective Representatives (a) with respect to all filings and notifications that Seller, the Company, or their Related Persons
shall be required by Legal Requirements to make in connection with the Contemplated Transactions and (b) 
in obtaining all material consents; provided, however, that Buyer shall not be required to dispose of or make any change
to its business, expend any material funds, or incur any other material obligation in order to comply with this Section 6.01.

 

Section
6.02 Notice.

 

(a)           
Prior to the Closing Date, Buyer shall promptly provide notice to Seller of any Breach of any representation or warranty
of Buyer or any fact or circumstance that would or would reasonably be likely to cause or constitute a Breach of any such representation
or warranty had that representation or warranty been made as of the time of the occurrence of such fact or circumstance. No such
notice will be deemed to have cured any Breach of any representation or warranty or affect any right or remedy of Seller under
this Agreement.

 

(b)          
Prior to the Closing Date, Buyer shall provide notice to Seller of any Breach of any covenant of Buyer in this ARTICLE VI
or any fact or circumstance that could make the satisfaction of any condition in ARTICLE VIII impossible or unlikely and of all
corrective actions undertaken, or to be undertaken, by Buyer with respect thereto. No such notice will be deemed to have cured
any Breach of any covenant or affect any right or remedy of Seller under this Agreement.

 

ARTICLE VII.

CONDITIONS PRECEDENT
TO

BUYER’S OBLIGATION TO CLOSE

 

Buyer’s
obligations to purchase the RRPC Interest and to take the other actions required pursuant to this Agreement to be taken by Buyer
at the Closing are subject to the satisfaction, at or prior to the Closing, of each of the following conditions (any of which may
be waived in whole or in part by Buyer):

 

Section
7.01 Accuracy of Sellers’ Representations.

 

 

 

    	 	13	 

     

    

 

(a)           
Subject to Section 7.01(b), each of Seller’s representations and warranties in this Agreement will have been accurate
in all material respects as of the date of this Agreement and will be accurate in all material respects as of the Closing Date
as if then made.

 

(b)           
Each of Seller’s representations and warranties in Sections 3.02(a) and 3.03, and each of the representations and
warranties in this Agreement that contains an express materiality qualification, will have been accurate in all respects as of
the date of this Agreement and will be accurate in all respects as of the Closing Date as if then made.

 

Section
7.02 Seller’s Performance. The covenants and obligations that Seller is required to perform or to comply with pursuant
to this Agreement at or prior to the Closing will have been duly performed and complied with in all material respects.

 

Section
7.03 Bring Down Certificate. Buyer will have received a certificate executed by Seller confirming (a) the accuracy of its
representations and warranties as of the date of this Agreement and as of the Closing Date in accordance with Section 7.01 and
(b) the performance of and compliance with its covenants and obligations to be performed or complied with at or prior to the Closing
in accordance with Section 7.02.

 

Section
7.04 Governmental Authorizations. Buyer will have received such Governmental Authorizations as are necessary or which it
considers desirable to allow Buyer to acquire and own the RRPC Interest and for the Company and Buyer to own and operate the business
of the Company from and after the Closing.

 

Section
7.05 No Conflict. Neither the consummation nor the performance of any Contemplated Transaction will, directly or indirectly
(with or without notice or lapse of time), contravene, conflict with, or violate, or cause Buyer or any Related Person of Buyer
to suffer any adverse consequence under, (a) any applicable Legal Requirement or Order or (b) any Legal Requirement or Order that
has been published, introduced, or otherwise proposed by or before any Governmental Body.

 

ARTICLE VIII.

CONDITIONS PRECEDENT
TO

SELLER’S OBLIGATIONS TO CLOSE

 

Seller’s
obligations to sell the RRPC Interest and to take the other actions required pursuant to this Agreement to be taken by Seller at
the Closing are subject to the satisfaction, at or prior to the Closing, of each of the following conditions (any of which may
be waived in whole or in part by Seller):

 

Section
8.01 Accuracy of Buyer’s Representations. Each of Buyer’s representations and warranties in this Agreement
will have been accurate in all material respects as of the date of this Agreement and will be accurate in all material respects
as of the Closing Date as if then made.

 

Section
8.02 Buyer’s Performance. The covenants and obligations that Buyer is required to perform or to comply with pursuant
to this Agreement at or prior to the Closing will have been duly performed and complied with in all material respects.

 

 

 

    	 	14	 

     

    

 

Section
8.03 Bring Down Certificate. Seller will have received a certificate executed by Buyer confirming (a) the accuracy of its
representations and warranties as of the date of this Agreement and as of the Closing Date in accordance with Section 8.01 and
(b) the performance of and compliance with its covenants and obligations to be performed or complied with at or prior to the Closing
in accordance with Section 8.02.

 

Section
8.04 No Legal Prohibition. There will not be in effect any Legal Requirement or Order that prohibits the sale of the RRPC
Interest by Seller to Buyer or the consummation of any of the other Contemplated Transactions.

 

ARTICLE
IX.

TERMINATION

 

Section
9.01 Termination Events. Subject to Section 9.02, by notice given prior to or at the Closing, this Agreement may be terminated
as follows:

 

 (a)            by mutual consent of Buyer and Seller;

 

(b)           
by Buyer if a material Breach of any provision of this Agreement has been committed by Seller;

 

(c)           
by Seller if a material Breach of any provision of this Agreement has been committed by Buyer;

 

(d)            by Buyer if satisfaction of any condition in ARTICLE VII by July 31, 2020 or such later date as the parties may agree upon
(the “End Date”) becomes impossible (other than through the failure of Buyer to comply with its obligations
under this Agreement);

 

(e)           
by Seller if satisfaction of any condition in ARTICLE VIII by the End Date becomes impossible (other than through the failure
of Seller to comply with its obligations under this Agreement);

 

(f)            
by Buyer if the Closing has not occurred on or before the End Date, unless Buyer is in material Breach of this Agreement;
or

 

(g)           
by Seller if the Closing has not occurred on or before the End Date, unless Seller are in material Breach of this Agreement.

 

Section
9.02 Effect of Termination. Each party’s right of termination under Section 9.01 is in addition to any other right
it may have under this Agreement (including under Section 12.13) or otherwise, and the exercise of a party’s right of termination
will not constitute an election of remedies. If this Agreement is terminated pursuant to Section 9.01, this Agreement will be of
no further force or effect; provided, however, that (i) this Section 9.02 and ARTICLE XII will survive the termination of this
Agreement and will remain in full force and effect, and (ii) the termination of this Agreement will not relieve any party from
any liability for any Breach of this Agreement occurring prior to termination.

 

 

 

    	 	15	 

     

    

 

ARTICLE X.

DISCLAIMERS,
RELEASE AND INDEMNITY

 

Section
10.01 Disclaimers by Seller. Except as expressly set forth in this Agreement, it is understood and agreed that Seller has
not at any time made and is not now making, and specifically disclaims, any warranties or representations of any kind or character,
express or implied, with respect to the Property, including, but not limited to, warranties or representations as to (i) matters
of title, (ii) environmental matters relating to the Property or any portion thereof, including, without limitation, the presence
of Hazardous Materials in, on, under or in the vicinity of the Property, (iii) geological conditions, including, without limitation,
subsidence, subsurface conditions, water table, underground water reservoirs, limitations regarding the withdrawal of water, and
geologic faults and the resulting damage of past and/or future faulting, (iv) whether, and to the extent to which the Property
or any portion thereof is affected by any stream (surface or underground), body of water, wetlands, flood prone area, flood plain,
floodway or special flood hazard or fire hazard, (v) drainage, (vi) soil conditions, including the existence of instability, past
soil repairs, soil additions or conditions of soil fill, or susceptibility to landslides, or the sufficiency of any undershoring,
(vii) the presence of endangered species or any environmentally sensitive or protected areas, (viii) zoning or building entitlements
to which the Property or any portion thereof may be subject, (ix) the availability of any utilities to the Property or any portion
thereof including, without limitation, water, sewage, gas and electric, (x) usages of adjoining property, (xi) access to the Property
or any portion thereof, (xii) the value, compliance with the plans and specifications, size, location, age, use, design, quality,
description, suitability, structural integrity, operation, title to, or physical or financial condition of the Property or any
portion thereof, or any income, expenses, charges, liens, encumbrances, rights or claims on or affecting or pertaining to the Property
or any part thereof, (xiii) the condition or use of the Property or compliance of the Property with any or all past, present or
future federal, state or local ordinances, rules, regulations or laws, building, fire or zoning ordinances, codes or other similar
laws, (xiv) the existence or non- existence of underground storage tanks, surface impoundments, or landfills, (xv) the merchantability
of the Property or fitness of the Property for any particular purpose, (xvi) the truth, accuracy or completeness of the Property
Documents, (xvii) tax consequences, or (xviii) any other matter or thing with respect to the Property.

 

Section
10.02 Sale “As Is, Where Is.” Buyer acknowledges and agrees that upon Closing, Seller shall sell and convey
to Buyer the RRPC Interest and Buyer shall accept the RRPC Interest and the Property “AS IS, WHERE IS, WITH ALL FAULTS,”
except to the extent expressly provided otherwise in this Agreement. Except as expressly set forth in this Agreement, Buyer has
not relied and will not rely on, and Seller has not made and is not liable for or bound by, any express or implied warranties,
guarantees, statements, representations or information pertaining to the Property or relating thereto (including specifically,
without limitation, Property information packages distributed with respect to the Property) made or furnished by Seller or any
broker, agent or third party representing or purporting to represent Seller, to whomever made or given, directly or indirectly,
orally or in writing. Buyer represents that it is a knowledgeable, experienced and sophisticated purchaser of real estate and
that, except as expressly set forth in this Agreement, it is relying solely on its own expertise and that of Buyer’s consultants
in purchasing the Property and shall make an independent verification of the accuracy of any documents and information provided
by Seller. Buyer will conduct such inspections and investigations of the Company and the Property as Buyer deems necessary, including,
but not limited to, the physical and environmental conditions thereof, and shall rely upon same. Buyer acknowledges that Seller
has afforded Buyer a full opportunity to conduct such inspections and investigations of the Property as Buyer deemed necessary
to satisfy itself as to the condition of the Property and the existence or non-existence or curative action to be taken with respect
to any Hazardous Materials on or discharged from the Property, and will rely solely upon same and not upon any information provided
by or on behalf of Seller or its agents or employees with respect thereto, other than such representations, warranties and covenants
of Seller as are expressly set forth in this Agreement. Upon the Closing, Buyer shall assume the risk that adverse matters, including,
but not limited to, adverse physical or construction defects or adverse environmental, health or safety conditions, may not have
been revealed by Buyer’s inspections and investigations.

 

 

 

    	 	16	 

     

    

 

	 	

                                                                       Buyer’s Initials 
	

 

Section
10.03 Seller Released from Liability.

 

(a)          
Buyer acknowledges that it has had the opportunity to inspect the Property and observe its physical characteristics and
existing conditions and the opportunity to conduct such investigations and studies on and of the Property and adjacent areas as
Buyer deems necessary, and Buyer hereby FOREVER RELEASES AND DISCHARGES Seller and Seller Parties from all responsibility and liability,
including without limitation, liabilities under the Comprehensive Environmental Response, Compensation and Liability Act of 1980
(42 U.S.C. § 9601 et seq.), as amended (“CERCLA”), regarding the condition, valuation, salability or utility
of the Property, and/or its suitability for any purpose whatsoever (including, but not limited to, with respect to the presence
in the soil, air, structures and surface and subsurface waters, of Hazardous Materials or other materials or substances that have
been or may in the future be determined to be toxic, hazardous, undesirable or subject to regulation and that may need to be specially
treated, handled and/or removed from the Property under current or future laws, regulations or guidelines, and any structural and
geologic conditions, subsurface soil and water conditions and solid and hazardous waste and Hazardous Materials on, under, adjacent
to or otherwise affecting the Property). This release includes claims of which Buyer is presently unaware or which Buyer does not
presently suspect to exist which, if known by Buyer, would materially affect Buyer’s release of Seller and Seller Parties.

 

(b)          
In this connection and to the extent permitted by law, Buyer hereby agrees, represents and warrants that Buyer realizes
and acknowledges that factual matters now unknown to it may have given or may hereafter give rise to causes of action, claims,
demands, debts, controversies, damages, costs, losses and expenses which are presently unknown, unanticipated and unsuspected,
and Buyer further agrees, represents and warrants that the waivers and releases herein have been negotiated and agreed upon in
light of that realization and that Buyer nevertheless hereby intends to release, discharge and acquit Seller and Seller Parties
from any such unknown causes of action, claims, demands, debts, controversies, damages, costs, losses and expenses.

 

(c)          
Buyer further hereby WAIVES (and by closing this transaction will be deemed to have WAIVED) any and all objections to or
complaints regarding (including, but not limited to, federal, state and common law based actions, and any private right of action
under, local, state and federal laws to which the Property is or may be subject, including, but not limited to, CERCLA, and Resource
Conservation and Recovery Act (42 U.S.C. § 6901 et seq.), as amended (“RCRA”)), concerning the physical
characteristics and any existing conditions of the Property, including, without limitation, structural and geologic conditions,
subsurface soil and water conditions and solid and hazardous waste and Hazardous Materials on, under, adjacent to or otherwise
affecting the Property. Buyer hereby assumes the risk of changes in applicable laws and regulations relating to past, present
and future environmental conditions on the Property and the risk that adverse physical characteristics and conditions, including,
without limitation, the presence of Hazardous Materials or other contaminants, may not have been revealed by its investigation.

 

 

 

    	 	17	 

     

    

 

(d)          
Buyer expressly waives the provisions of Section 1542 of the California Civil Code which provides:

 

“A GENERAL RELEASE
DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME
OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR
OR RELEASED PARTY.”

 

and all similar provisions
or rules of law. Buyer elects to and does assume all risk for such Claims heretofore and hereafter arising, whether now known or
unknown by Buyer.

BY
INITIALING BELOW, BUYER HEREBY WAIVES THE PROVISIONS OF SECTION 1542 SOLELY IN CONNECTION WITH THE MATTERS WHICH ARE THE SUBJECT
OF THE FOREGOING WAIVERS AND RELEASES:

 

	 	

                                                                       Buyer’s Initials 
	

 

Notwithstanding the foregoing
provisions of this Section 10.03 to the contrary, such release of Seller and Seller Parties contained herein shall not relieve
Seller of liability for any breach by Seller of Seller’s representations and warranties in ARTICLE III, which expressly survive
Closing in accordance with the provisions of, and subject to the limitations of Section 7.01(b).

 

Section
10.04 Disclosure Requirement Compliance.

 

(a)           
Buyer and Seller acknowledge that Seller may be required to disclose if the Property lies within the following natural
hazard areas or zones: (i) a special flood hazard area designated by the Federal Emergency Management Agency (California Civil
Code Section 1102.17); (ii) an area of potential flooding (California Government Code Section 8589.4); (iii) a very high fire
hazard severity zone (California Government Code Section 51183.5); (iv) a wild land area that may contain substantial forest fire
risks and hazards (Public Resources Code Section 4136); (v) earthquake fault zone (Public Resources Code Section 2621.9); or (vi)
a seismic hazard zone (Public Resources Code Section 2694) (sometimes all of the preceding are herein collectively called the
“Natural Hazard Matters”). Seller has engaged or will engage the services of a third- party (who, in such capacity,
is herein called the “Natural Hazard Expert”) to examine the maps and other information specifically made available
to the public by government agencies for the purposes of enabling Seller to fulfill its disclosure obligations, if and to the
extent such obligations exist, with respect to the natural hazards referred to in California Civil Code Section 1102.6a (as amended)
and to report the result of its examination to Buyer and Seller in writing. The written report prepared by the Natural Hazard
Expert regarding the results of its full examination will fully and completely discharge Seller from its disclosure obligations
referred to herein, if and to the extent any such obligations exist, and, for the purpose of this Agreement, the provisions of
Civil Code Section 1102.4 regarding non liability of Seller for errors or omissions not within its personal knowledge shall be
deemed to apply and the Natural Hazard Expert shall be deemed to be an expert, dealing with matters within the scope of its expertise
with respect to the examination and written report regarding the natural hazards referred to above.

 

 

 

    	 	18	 

     

    

 

(b)          
Section 25359.7 of the California Health and Safety Code requires owners of non-residential real property who know, or have
reasonable cause to believe, that any release of hazardous substance has come to be located on or beneath the real property to
provide written notice of such to a buyer of the real property. Buyer acknowledges and agrees that the sole inquiry and investigation
Seller has conducted in connection with the environmental condition of the Property is to obtain and/or review those certain environmental
assessments and studies of the Property delivered to Buyer pursuant to this Agreement (collectively, “Seller’s Environmental
Reports”). Buyer (a) acknowledges Buyer’s receipt of the foregoing notice given pursuant to Section 25359.7 of
the California Health and Safety Code; (b) will be, prior to the end of the Inspection Period, fully aware of the matters described
in Seller’s Environmental Reports; and (c) after receiving advice of Buyer’s legal counsel, waives any and all rights
Buyer may have to assert that Seller has not complied with the requirements of Section 25359.7 of the California Health and Safety
Code. The representations, warranties and agreements set forth herein shall survive the consummation of the transactions contemplated
hereby.

 

Section
10.05 Survival. The terms and conditions of this ARTICLE X shall expressly survive the Closing, not merge with the provisions
of any other document or instrument and shall be incorporated into the Deed.

 

Buyer acknowledges and agrees
that the disclaimers and other agreements set forth herein are an integral part of this Agreement and that Seller would not have
agreed to sell the Property to Buyer for the Purchase Price without the disclaimers and other agreements set forth above.

 

ARTICLE
XI.

INDEMNIFICATION; PAYMENT;

REIMBURSEMENT; REMEDIES

 

Section
11.01 Survival; Remedies.

 

(a)          
All representations, warranties, covenants, and obligations in this Agreement and any certificate, document, or other writing
delivered pursuant to this Agreement will survive the Closing and the consummation and performance of the Contemplated Transactions.

 

(b)          
The right to indemnification, payment, reimbursement, or other remedy based upon any such representation, warranty, covenant,
or obligation will not be affected by any investigation (including any environmental investigation or assessment) conducted or
any Knowledge acquired at any time, whether before or after the execution and delivery of this Agreement or the Closing Date,
with respect to the accuracy or inaccuracy of, or compliance with, such representation, warranty, covenant, or obligation.

 

 

 

    	 	19	 

     

    

 

(c)          
The waiver of any condition relating to any representation, warranty, covenant, or obligation will not affect the right
to indemnification, payment, reimbursement, or other remedy based upon such representation, warranty, covenant, or obligation.

 

Section
11.02 Indemnification, Payment, and Reimbursement by Seller. Seller, jointly and severally, shall indemnify and hold harmless
Buyer, the Company, and their respective Representatives, shareholders, subsidiaries, and Related Persons (collectively, the “Buyer
Indemnified Persons”) from, and shall pay to Buyer Indemnified Persons the amount of, or reimburse Buyer Indemnified
Persons for, any Loss that Buyer Indemnified Persons or any of them may suffer, sustain, or become subject to, as a result of,
in connection with, or relating to:

 

(a)           
any Breach of any representation or warranty made by Seller in (i) this Agreement, (ii) the certificate delivered pursuant
to Section 7.03 (without giving effect to the words “in all material respects” in Section 7.01(a)), or (iii) any other
certificate, document, or other writing delivered by Seller pursuant to this Agreement;

 

(b)          
any Breach of any covenant or obligation of Seller in this Agreement or in any certificate, document, or other writing
delivered by Seller pursuant to this Agreement. or Notwithstanding the foregoing, Seller shall not have any liability for indemnifying
any Buyer Indemnified Party with respect to (i) any of the matters referred to in Section 4.06 or (ii) any fees or commissions
payable to any of the Persons listed on Schedules 3.08 or 4.05.

 

Section
11.03 Indemnification, Payment, and Reimbursement by Buyer. Buyer shall indemnify and hold harmless Seller and its Representatives,
shareholders, Subsidiaries, and Related Persons (collectively, the “Seller Indemnified Persons”) from, and shall
pay to Seller the amount of, or reimburse Seller for, any Loss that Seller or any of them may suffer, sustain, or become subject
to, as a result of, in connection with, or relating to:

 

(a)           
any Breach of any representation or warranty made by Buyer in (i) this Agreement, (ii) the certificate delivered pursuant
to Section 8.03, or (iii) in any other certificate, document, or other writing delivered by Buyer pursuant to this Agreement;

 

(b)          
any Breach of any covenant or obligation of Buyer in this Agreement or in any certificate, document, or other writing delivered
by Buyer pursuant to this Agreement;

 

(c)           
any claim or Loss arising out of or related to the CPL Actions, the Mechanic’s Liens Actions, the Accident Lawsuits
and the Spacebugs Action, or any of the matters referred to in Section 4.06.

 

(d)           
any claim by any Person for brokerage or finder’s fees or commissions or similar payments based upon any agreement
or understanding made, or alleged to have been made, by any such Person with Buyer (or any Person acting on its behalf) in connection
with any Contemplated Transaction.

 

 

 

    	 	20	 

     

    

 

Section
11.04 Time Limitations.

 

(a)           
If the Closing occurs, Seller shall have liability under Section 11.02(a) with respect to any Breach of a representation
or warranty (other than those in Sections 3.01, 3.02 or 3.03, as to which a claim may be made at any time), only if on or before
the date that is six months after the Closing Date, Buyer notifies Seller of a claim, specifying the factual basis of the claim
in reasonable detail to the extent known by Buyer.

 

(b)          
If the Closing occurs, Buyer shall have liability under Section 11.03(a) with respect to any Breach of a representation
or warranty (other than those in Sections 4.01, 4.02, and 4.05, as to which a claim may be made at any time), only if on or before
the date that is six months after the Closing Date, Seller notify Buyer of a claim specifying the factual basis of the claim in
reasonable detail to the extent known by Seller.

 

Section
11.05 Certain Limitations on Amount.

 

(a)          
If the Closing occurs, Seller shall have no liability with respect to claims under Section 11.02(a) until the aggregate
of all Losses suffered by all Buyer Indemnified Persons with respect to such claims exceeds $50,000; provided, however, that if
the aggregate of all such Losses exceeds $50,000, Seller shall be liable for all such Losses. However, this Section 11.05(a) will
not apply to any Breach of which a Seller has Knowledge at any time at or prior to the date on which such representation and warranty
was made or to any Breach of any representation or warranty in Sections 3.01, 3.02 or 3.03.

 

(b)          
If the Closing occurs, Buyer shall have no liability with respect to claims under Section 11.03(a) until the aggregate of
all Losses suffered by all Seller Indemnified Persons with respect to such claims exceeds $50,000; provided, however, that if the
total of all such Losses exceeds $50,000, Buyer shall be liable for all such Losses. However, this Section 11.05(b) will not apply
to any Breach of which Buyer has Knowledge at any time at or prior to the date on which such representation and warranty was made
or to any Breach of any representation or warranty in Section 4.01, 4.02, or 4.05.

 

Section
11.06 Third-Party Claims.

 

(a)           
A Person benefited by Section 11.02 or Section 11.03 (an “Indemnified Person”) shall give notice of the
assertion of a Third-Party Claim to Seller or Buyer (an “Indemnifying Person”), as the case may be; provided,
however, that no failure or delay on the part of an Indemnified Person in notifying an Indemnifying Person will relieve the Indemnifying
Person from any obligation under this Section 11.06 except to the extent that the failure or delay materially prejudices the defense
of the Third-Party Claim by the Indemnifying Person.

 

(b)           
Except as provided in Section 11.06(e), the Indemnifying Person may elect to assume the defense of the Third-Party Claim
with counsel satisfactory to the Indemnified Person by (A) giving notice to the Indemnified Person of its election to assume the
defense of the Third- Party Claim and (B) giving the Indemnified Person evidence acceptable to the Indemnified Person that the
Indemnifying Person has adequate financial resources to defend against the Third-Party Claim and fulfill its obligations under
this Section 11.06, in each case no later than 10 days after the Indemnified Person gives notice of the assertion of a Third-Party
Claim under Section 11.06(a).

 

 

 

    	 	21	 

     

    

 

 (c)            If the Indemnifying Person elects to assume the defense of a Third-Party Claim:

 

(i)           
it shall diligently conduct the defense and, so long as it diligently conducts the defense, shall not be liable to the Indemnified
Person for any Indemnified Person’s fees or expenses subsequently incurred in connection with the defense of the Third-Party
Claim other than reasonable costs of investigation;

 

(ii)           
the election will conclusively establish for purposes of this Agreement that the Indemnified Person is entitled to relief
under this Agreement for any Loss arising, directly or indirectly, from or in connection with the Third-Party Claim (subject to
the provisions of Section 11.05);

 

(iii)         
no compromise or settlement of such Third-Party Claim may be effected by the Indemnifying Person without the Indemnified
Person’s consent unless (I) there is no finding or admission of any violation by the Indemnified Person of any Legal Requirement
or any rights of any Person, (II) the Indemnified Person receives a full release of and from any other claims that may be made
against the Indemnified Person by the Third Party bringing the Third-Party Claim, and (III) the sole relief provided is monetary
damages that are paid in full by the Indemnifying Person; and

 

(iv)          
the Indemnifying Person shall have no liability with respect to any compromise or settlement of such claims effected without
its consent.

 

(d)        	   If the Indemnifying Person does not assume the defense of a Third-Party

 

Claim in the manner and within
the period provided in Section 11.06(b), or if the Indemnifying Person does not diligently conduct the defense of a Third-Party
Claim, the Indemnified Person may conduct the defense of the Third-Party Claim at the expense of the Indemnifying Person and the
Indemnifying Person shall be bound by any determination resulting from such Third-Party Claim or any compromise or settlement effected
by the Indemnified Person.

 

(e)          
Notwithstanding the foregoing, if an Indemnified Person determines in good faith that there is a reasonable probability
that a Third-Party Claim may adversely affect it or any Related Party other than as a result of monetary damages for which it would
be entitled to relief under this Agreement, the Indemnified Person may, by notice to the Indemnifying Person, assume the exclusive
right to defend, compromise, or settle such Third-Party Claim.

 

(f)           
Notwithstanding the provisions of Section 12.10, Seller consent to the nonexclusive jurisdiction of any court in which
a Proceeding is brought against any Indemnified Person for purposes of determining any claim that an Indemnified Person may have
under this Agreement with respect to such Proceeding or the matters alleged therein.

(g)           	With respect to any Third-Party Claim subject to this ARTICLE XI:

 

(i)           
any Indemnified Person and any Indemnifying Person, as the case may be, shall keep the other Person fully informed of the
status of such Third-Party Claim and any related Proceeding at all stages thereof where such Person is not represented by its own
counsel; and

 

 

 

    	 	22	 

     

    

 

(ii)           
both the Indemnified Person and the Indemnifying Person, as the case may be, shall render to each other such assistance
as they may reasonably require of each other and shall cooperate in good faith with each other in order to ensure the proper and
adequate defense of any Third-Party Claim.

 

(h)          
With respect to any Third-Party Claim subject to this ARTICLE XI, the parties shall cooperate in a manner to preserve in
full (to the extent possible) the confidentiality of all confidential information and the attorney-client and work-product privileges.
In connection therewith, each party agrees that:

 

(i)           
it shall use its best efforts, in respect of any Third-Party Claim in which it has assumed or participated in the defense,
to avoid production of confidential information (consistent with applicable law and rules of procedure); and

 

(ii)          
all communications between any party and counsel responsible for or participating in the defense of any Third-Party Claim
shall, to the extent possible, be made so as to preserve any applicable attorney-client or work-product privilege.

 

(i)            
Any claim under this ARTICLE XI for any matter involving a Third-Party Claim shall be indemnified, paid, or reimbursed promptly.
If the Indemnified Person shall for any reason assume the defense of a Third-Party Claim, the Indemnifying Person shall reimburse
the Indemnified Person on a monthly basis for the costs of investigation and the reasonable fees and expenses of counsel retained
by the Indemnified Person.

 

Section
11.07 Other Claims. A claim under this ARTICLE XI for any matter not involving a Third-Party Claim may be made by notice
to Seller or Buyer, as the case may be, and shall be indemnified, paid, or reimbursed promptly after such notice.

 

Section
11.08 Strict Liability or Indemnitee Negligence. THE PROVISIONS IN THIS ARTICLE XI SHALL BE ENFORCEABLE REGARDLESS OF WHETHER
THE LIABILITY IS BASED UPON PAST, PRESENT, OR FUTURE ACTS, CLAIMS, OR LEGAL REQUIREMENTS (INCLUDING ANY PAST, PRESENT, OR FUTURE
ENVIRONMENTAL LAW, OCCUPATIONAL SAFETY AND HEALTH LAW, OR PRODUCTS LIABILITY, SECURITIES, OR OTHER LEGAL REQUIREMENT) AND REGARDLESS
OF WHETHER ANY PERSON (INCLUDING THE PERSON FROM WHOM RELIEF IS SOUGHT) ALLEGES OR PROVES THE SOLE, CONCURRENT, CONTRIBUTORY, OR
COMPARATIVE NEGLIGENCE OF THE PERSON SEEKING RELIEF, OR THE SOLE OR CONCURRENT STRICT LIABILITY IMPOSED UPON THE PERSON SEEKING
RELIEF.

 

ARTICLE XII.

MISCELLANEOUS

 

Section
12.01 Expenses.

 

(a)           
Except as otherwise provided in this Agreement or the other documents to be delivered pursuant to this Agreement, each
party will bear its respective fees and expenses incurred in connection with the preparation, negotiation, execution, and performance
of this Agreement and the consummation and performance of the Contemplated Transactions, including all fees and expenses of its
Representatives. Buyer will pay the fees and expenses of the Escrow Agent under the Escrow Agreement. The Company has not incurred,
and Seller will cause the Company not to incur, any fees or expenses in connection with this Agreement and the Contemplated Transactions;
provided, however, that to the extent such fees and expenses have been incurred by the Company, Seller will reimburse the Company
for such fees and expenses prior to the Closing. The obligation of each party to bear its own fees and expenses will be subject
to any rights of such party arising from a Breach of this Agreement by another party.

 

 

 

    	 	23	 

     

    

 

(b)           
All stamp, documentary, and other transfer taxes (including any penalties and interest) incurred in connection with this
Agreement, whether pertaining to the RRPC Interest or any assets and properties of the Company, will be paid by Seller. Seller
will, at its own expense, file all necessary tax returns and other documentation with respect to all such taxes.

 

(c)          
Buyer shall be responsible for the payment of those expenses set forth on Schedule 12.01, totaling $577,243.12, which
were incurred on behalf of the Company prior to the date hereof. Buyer shall be responsible for all other accrued costs and expenses
of the Company, including contingent liabilities, whether incurred before or after the Closing Date.

 

Section
12.02 Public Announcements. Notwithstanding any confidentiality obligation to which Buyer is subject, any public announcement,
including any press release, communication to employees, customers, suppliers, or others having dealings with the Company, or similar
publicity with respect to this Agreement or any Contemplated Transaction, will be issued, at such time, in such manner, and containing
such content as Buyer determines.

 

Section
12.03 Further Assurances. The parties will (a) execute and deliver to each other such other documents and (b) do such other
acts and things as a party may reasonably request for the purpose of carrying out the intent of this Agreement, the Contemplated
Transactions, and the documents to be delivered pursuant to this Agreement.

 

Section
12.04 Entire Agreement. This Agreement supersedes all prior agreements, whether written or oral, between the parties with
respect to its subject matter (including any letter of intent and, upon the Closing, any confidentiality obligation to which Buyer
is subject) and constitutes (along with the schedules, and the other documents to be delivered pursuant to this Agreement) a complete
and exclusive statement of the terms of the agreement between the parties with respect to the subject matter of this Agreement.

 

Section
12.05 Modification. This Agreement may only be amended, supplemented, or otherwise modified by a writing executed by Buyer
and Seller.

 

Section
12.06 Assignments and Successors. No party may assign any of its rights or delegate any of its obligations under this Agreement
without the prior consent of the other parties. Any purported assignment of rights or delegation of obligations in violation of
this Section 12.06 will be void. Subject to the foregoing, this Agreement will apply to, be binding in all respects upon, and inure
to the benefit of the heirs, executors, administrators, legal representatives, successors, and permitted assigns of the parties.

 

Section
12.07 No Third-Party Rights. Other than the Indemnified Persons and the parties, no Person will have any legal or equitable
right, remedy, or claim under or with respect to this Agreement. This Agreement may be amended or terminated, and any provision
of this Agreement may be waived, without the consent of any Person who is not a party to the Agreement.

 

 

 

    	 	24	 

     

    

 

Section
12.08 Remedies Cumulative. The rights and remedies of the parties are cumulative and not alternative.

 

Section
12.09 Governing Law. All matters relating to or arising out of this Agreement or any Contemplated Transaction and the rights
of the parties (whether sounding in contract, tort, or otherwise) will be governed by and construed and interpreted under the laws
of the State of California without regard to conflicts of laws principles that would require the application of any other law.

 

Section
12.10 Jurisdiction; Service of Process. Except as otherwise provided in this Agreement, any Proceeding arising out of or
relating to this Agreement or any Contemplated Transaction shall be brought in the courts of the State of California, County of
Los Angeles, or, if it has or can acquire jurisdiction, in the United States District Court for the Central District of California,
and each of the parties irrevocably submits to the exclusive jurisdiction of each such court in any such Proceeding, waives any
objection it may now or hereafter have to venue or to convenience of forum, agrees that all claims in respect of such Proceeding
shall be heard and determined only in any such court, and agrees not to bring any Proceeding arising out of or relating to this
Agreement or any Contemplated Transaction in any other court. Each party acknowledges and agrees that this Section 12.10 constitutes
a voluntary and bargained-for agreement between the parties. Process in any Proceeding referred to in the first sentence of this
Section 12.10 or in Section 11.06(f) may be served on any party anywhere in the world, including by sending or delivering a copy
of the process to the party to be served at the address and in the manner provided for the giving of notices in Section 12.15.
Nothing in this Section 12.10 will affect the right of any party to serve legal process in any other manner permitted by law or
at equity.

 

Section
12.11 Waiver of Jury Trial. EACH PARTY, KNOWINGLY, VOLUNTARILY, AND INTENTIONALLY, WAIVES ITS RIGHT TO TRIAL BY JURY IN
ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY CONTEMPLATED TRANSACTION, WHETHER SOUNDING IN CONTRACT, TORT,
OR OTHERWISE.

 

Section
12.12 Attorneys’ Fees. In the event any Proceeding is brought in respect of this Agreement or any of the documents
referred to in this Agreement, the prevailing party will be entitled to recover reasonable attorneys’ fees and other costs
incurred in such Proceeding, in addition to any relief to which such party may be entitled.

 

Section
12.13 Enforcement of Agreement.Seller acknowledge and agree that Buyer would be irreparably harmed if any of the provisions
of this Agreement are not performed in accordance with their specific terms and that any Breach of this Agreement by Seller could
not be adequately compensated in all cases by monetary damages alone. Accordingly, Seller agree that, in addition to any other
right or remedy to which Buyer may be entitled at law or in equity, Buyer shall be entitled to enforce any provision of this Agreement
by a decree of specific performance and to obtain temporary, preliminary, and permanent injunctive relief to prevent Breaches or
threatened Breaches, without posting any bond or giving any other undertaking.

 

 

 

    	 	25	 

     

    

 

Section
12.14 No Waiver. Neither any failure nor any delay by any party in exercising any right, power, or privilege under this
Agreement or any of the documents referred to in this Agreement will operate as a waiver of such right, power, or privilege, and
no single or partial exercise of any such right, power, or privilege will preclude any other or further exercise of such right,
power, or privilege or the exercise of any other right, power, or privilege. To the maximum extent permitted by applicable Legal
Requirements, (a) no claim or right arising out of this Agreement or any of the documents referred to in this Agreement can be
waived by a party, in whole or in part, unless made in a writing signed by such party or Seller on behalf of a Seller; (b) a waiver
given by a party will only be applicable to the specific instance for which it is given; and (c) no notice to or demand on a party
will (i) waive or otherwise affect any obligation of that party or (ii) affect the right of the party giving such notice or demand
to take further action without notice or demand as provided in this Agreement or the documents referred to in this Agreement.

 

Section
12.15 Notices. All notices and other communications required or permitted by this Agreement shall be in writing and will
be effective, and any applicable time period shall commence, when (a) delivered to the following address by hand or by a nationally
recognized overnight courier service (costs prepaid) addressed to the following address or (b) transmitted electronically to the
following facsimile numbers or e-mail addresses, in each case marked to the attention of the Person (by name or title) designated
below (or to such other address, facsimile number, e-mail address, or Person as a party may designate by notice to the other parties):

 

Seller:

 

Bristol Capital

1 Robins Lane

Kinnelon, NJ 07405

Attention: Joel Stoesser

Email: jwstoesser@jwsadv.com

 

with a copy to:

 

Shumaker Mallory LLP

468 N. Camden Dr., Suite 350, Beverly Hills, CA
90210

Attention: Bennett J. Yankowitz

Email: Yankowitz@smcounsel.com

 

Buyer:

 

Cannapharmarx Inc.

Suite 206 – 1180 Sunset Drive

Kelowna, British Columbia, V1Y9W6 Canada

Attention:
Nick Colvin

Email: ncolvin@cannapharmarx.com

 

Copy to:

 

Brinen & Associates, LLC

90 Broad Street, Tenth Floor New York, New
York 10004

Attention: Joshua D. Brinen

Email: jbrinen@brinenlaw.com

           service@brinenlaw.com

 

 

 

    	 	26	 

     

    

 

Section
12.16 Severability. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction,
the other provisions of this Agreement will remain in full force and effect. Any provision of this Agreement held invalid or unenforceable
only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

Section
12.17 Time of Essence. With regard to all dates and time periods set forth or referred to in this Agreement, time is of
the essence.

 

Section
12.18 Counterparts and Electronic Signatures.

 

(a)       
This Agreement and other documents to be delivered pursuant to this Agreement may be executed in one or more counterparts,
each of which will be deemed to be an original copy and all of which, when taken together, will be deemed to constitute one and
the same agreement or document, and will be effective when counterparts have been signed by each of the parties and delivered to
the other parties.

 

(b)      
A manual signature on this Agreement or other documents to be delivered pursuant to this Agreement, an image of which shall
have been transmitted electronically, will constitute an original signature for all purposes. The delivery of copies of this Agreement
or other documents to be delivered pursuant to this Agreement, including executed signature pages where required, by electronic
transmission will constitute effective delivery of this Agreement or such other document for all purposes.

 

[signature Pages Follow]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	27	 

     

    

 

IN WITNESS WHEREOF, the parties
have executed and delivered this Agreement as of the date first written above.

 

 

	Buyer:	CANNAPHARMARX INC.
	 	a
Delaware corporation
	 	 
	 	/s/ Dominic Colvin
	 	Name: Dominic Colvin
	 	Title:   President and CEO
	 	 
	 	 
	 	 
	 	 
	Seller:	BRISTOL CAPITAL INVESTORS, LLC
	 	a Delaware limited liability company
	 	 
	 	 
	 	By: /s/ Joel W. Stoesser
	 	Joel W. Stoesser, Authorized Representative

 

 

 

 

 

 

 

    	 	28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]